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ABSTRACT
Phylogenetic Studies of the United States Bluetongue
Viruses and Characterization of the
Viral VP4 Protein
by
I-Jen Huang, Doctor of Philosophy
Utah State University, 1996
Major Professor: Dr. Joseph K.-K. Li
Department: Biology (Molecular Biology)
Bluetongue Vlrus (BTV) lS transmitted by arthropod
vectors and causes bluetongue disease with serious economic
loss in many regions of the world.

The replication mechanism

of bluetongue virus is still not clear.

To have a better

understanding regarding the viral replication, the function
of each individual protein has to be identified.

This study

used molecular biology techniques to investigate the function
of the inner core protein VP4.
The M1 genes of United States bluetongue Vlrus
serotypes-2, -10, -11, -13, and -17 were cloned and
sequenced.
nucleotides.

The length of each of the five M1 genes is 1981
The coding region of the M1 gene, which encodes

the VP4 protein, possesses an open reading frame with an

lV
initiation codon (ATG) at nucleotides #9-11 and a stop codon
(TAA) at nucleotides #1941-1943.

This open reading frame

encodes a protein of 644 amino acid residues with a predicted
molecular weight of about 75 kDa.

A potential leucine zipper

motif was detected near the carboxyl terminus of the deduced
VP4 amino acid sequence.

The phylogenetic analysis of

bluetongue viruses using the sequences of these five cognate
M1 genes is consistent with the results of previous
phylogenetic studies.

Serotypes-10, -11, -13, and -17 are

closely related and serotype-2 is the most distantly related
among the five US BTV serotypes.
Heterologously expressed bluetongue Vlrus VP4 protein
was purified to near homogeneity.

Six linear epitopes of

VP4 were mapped at both termini and in the middle of the
protein.

By using enzyme-linked irnrnunosorbent assay and

peptide competition assay, slx linear epitopes were found
to be surface accessible.

The VP4 protein was shown to be

an oligomer by chemical cross-linking.

VP4 protein was

identified as a ssRNA-binding protein.

The VP4 protein has

binding activity towards both capped and non-capped ssRNA.
RNA-binding activity was not specific to BTV ssRNA.

A

leucine-zipper motif of VP4 is not required for RNA-binding
activity. One RNA-binding domain was mapped between amino
acid residues #112-158 by a Northwestern assay and by

v
deletion mutant analysis.

Using sequence-specific

synthetic peptides corresponding to VP4 in the arginineand lysine-rich regions,

four potential ssRNA-binding

domains of VP4 protein were mapped.
(190 pages)
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CHAPTER I
LITERATURE REVIEW AND PROJECT OUTLINE

INTRODUCTION

Bluetongue viruses
In the early twentieth century, Spreull (1905)
described an animal disease that he believed to be found ln
South Africa only.

The infected sheep had high fever

lasting for 5 to 7 days followed by conspicuous lesions
that emerged in the mouth.

The tongue was severely

affected and became dark blue.

Spreull proposed

"bluetongue" as the name of this disease.

This disease was

later found in both domestic animals (sheep, goat, cattle,
etc.) and in wild ruminants (blesbuck, elk, etc.) in most
parts of the world.

Bluetongue disease is an infectious,

noncontagious, arthropod-borne viral disease, mostly of
sheep (Erasmus, 1975).

The disease can occur, clinically,

as an acute, subacute, mild, or inapparent disease.

In

domestic sheep and white-tailed deer (Odocoileus
virginianus), clinical signs occur rapidly within a short

viral incubation.

Goats, cattle, elk (Cervus elaphus

canadensis), and other wild ruminants develop subacute or

inapparent infections and are considered to have a longer
viremia (Sohn and Yuill, 1991).

The first sign of the
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bluetongue disease is that the infected animal's body
temperature rises with an average duration of 5 to 7 days,
which may be transitory or continue for up to 14 days.

In

most of the cases, hyperemia and swelling of the buccal and
nasal mucosa are observed at the time of temperature rise.
The mouth area will have lesions resulting in excoriation,
leaving bleeding, ulcerated lesions, which become infected
and often necrotic.

During this time the infected sheep

develops lethargy and anorexla.

Death may result from

lesions of the smooth muscle of the esophagus and
pharyngeal area and from heart failure
1986b).

(Marht and Osburn,

Abortion, fetal death, and congenital

malformations are also associated with bluetongue disease
(Luedke et al., 1977; Osburn et al., 1971).

The potential

danger of this disease was intensively discussed ln an
international symposium on bluetongue in 1974.

Geering

(1975) suggested that bluetongue disease was ln an
epizootic situation and could cause a mortality rate up to
70 % ln a highly susceptible sheep population.
The bluetongue disease is caused by bluetongue Vlrus
(BTV) classified in the Orbivirus genus of the family
Reoviridae (Borden et al., 1971; Murphy et al., 1971). The

Vlruses are transmitted among animals by insect vectors
such as the biting midges of the species Culicoides (Wirth
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and Dyce, 1985) and distributed to most parts of the world.

Orbivirus is designated for & group of viruses that are
spread by arthropods and have similar morphological
characteristics (Borden et al., 1971).

The word "orbi"

means circle or ring, referring to the round-shaped surface
of this group of viruses.

This group of viruses shares

similar morphological and physicochemical features within
the family Reoviridae, but there is not a common antigen to
all v1ruses in the Orbivirus genus (Borden et al., 1971;
Verwoerd et al., 1979).

There are 14 serogroups 1n this

genus distinguished by complement fixation tests

(Borden et

al., 1971; Karabatsos, 1985), including African horse
sickness, bluetongue, changuinola, corriparta, epizootic
hemorrhagic disease, equine encephalosis, eubenangee,
lebombo, orungo, palyam, umatilla, wallal, warrego, and
kemerovo.

Based on neutralization tests, there are 24

serotypes of BTV identified around the world, and only five
serotypes (BTV-2, -10, -11, -13, and -17) are found in
United States (US)

(Barber, 1979; Mecham et al., 1986; Roy,

1989).
Bluetongue v1rus 1s an icosahedral-shaped particle
consisting of a double-layered protein coat and has a 10segmented double-stranded RNA (dsRNA) genome (Verwoerd et

al., 1972).

The double-layer viral protein coat contains
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two outer capsid proteins (VP2 and VP5) and five lnner core
proteins (VP1, VP3, VP4, VP6, and VP7).

Similar to

rotavirus and reovirus, BTV has concentric protein shells
and has no envelope.

The negatively stained BTV virion has

a fuzzy appearance and a diameter of about 70 nm (Verwoerd
et al., 1972; Martin and Zweerink, 1972).

It does not have

any discernible structure, although virus-derived cores
have icosahedral symmetry.

Using cryoelectron micrographic

image analyses, the outer capsid has revealed a wellordered morphology, and it is different from those of human
rotavirus and reovirus (Prasad et al., 1988; Yeager et al.,
1990; Metcalf et al., 1991).

From these images the

proteins of the outer capsid have two shapes; one is
globular and the other is sail-shaped (Hewat et al., 1992).
The sail-shaped spikes are predicted to be the
haemagglutinating protein VP2, which contains the Vlrusneutralizing epitope.
likely to be VP5.

The globular-shaped protein is more

The structure of the inner core has been

examined by cryoelectron microscopy to a resolution of 30A.
The inner core has a diameter of 69 nrn, and it contains 260
copies of VP7 trimers and 120 copies of VP3

al., 1995).

(Burroughs et

The crystal structure of the inner core was

recently grown up to 0.8 rom in diameter.

The dimensions

are 754 x 796 x 823A 3 (Burroughs et al., 1995).

The second
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layer of the inner core contains the remaining three minor
proteins

(V~1,

VP4, and VP6)

and the genomic dsRNA.

A loss

of infectivity is found after one or two of the outer
capsid proteins are removed.

Both divalent and monovalent

cations are able to destabilize the outer capsid layer
(Huismans et al., 1987c).

The inner core particles are

stable at a pH as low as 5, and the virions are the most
stable at the pH range of 8 to 9.

BTV virions are also

stable ln nonionic detergent and in lipid solvents
(Huismans et al., 1987c; Mertens et al., 1987; Verwoerd et

al . , 19 7 9) .
Verwoerd and his colleagues

(1970) separated the

genome of BTV into 10 segments using polyacrylamide gel
electrophoresis.

The electrophoretic pattern of the

genomic RNA segments is quite different from that of
reovirus, and the molecular weight of the BTV genome lS
estimated to be 19 x 10 6 Da (Fukusho et al., 1989).
Most dsRNA segments of the five US BTV serotypes have
been cloned and sequenced recently.
ranges from 3944 to 822 base pairs

The length of segment
(bp) .

The lengths of

the corresponding dsRNA segments of each serotype of BTV
are identical or very similar, and their sequences of
cognate genes are all highly conserved.

A sequence of slx

nucleotides at the 5'-and 3'- end of all BTV dsRNA segments

6
lS

conserved; however, the significance of this sequence

conservation is still unknown.

The migration profiles of

the genomic dsRNA segments on a polyacrylamide gel are
different for each BTV serotype.

This characteristic can

be used to distinguish different serotypes of BTV
diagnostically.
Viral proteins
Each of the 10 segments of the viral genome except the
S4 gene codes for one polypeptide ·(Grubman et al., 1983;
Sanger and Mertens, 1983; Roy, 1989; Evans-Wade et al.,
1992).

The double-layer viral protein coat contains two

outer capsid proteins (VP2 and VP5) and five inner core
proteins (VP1, VP3, VP4, VP6, and VP7). Four nonstructural
proteins (NS1, NS2, NS3, and NS3A) have also been detected
in BTV-infected cells (Hyatt et al., 1991) and by in vitro
translation (Grubman et al., 1983; Mertens et al., 1984;
Van Dijk and Huismans, 1988).

The viral structural

proteins from purified virions can be resolved by SDSpolyacrylamide gel electrophoresis (SDS-PAGE)
distinctive patterns for each serotype.

into

Thus, each

serotype of BTV can be distinguished by comparing the
electrophorogram patterns in addition to the neutralization

7

assay.

The following are the known characteristics of

these viral proteins.
VPl protein

VP1, the largest protein of BTV, 1s one of the minor
inner core proteins and is coded by the L1 gene.

Only six

copies of VP1 are potentially present in each virion
(Huismans and Van Dijk, 1990).

The L1 gene has 3944

nucleotides (Huang et al., 1995) and is highly conserved
among five US BTVs.

VP1 is a highly basic protein with a

positively charged carboxyl terminus.

The molecular weight

of VP1 is estimated to be 150 kDa from the deduced amino
acid sequences (Huang et al., 1995).
The deduced amino acid sequence of VP1 has about 30 %
identity with those of some of the prokaryotic and
eukaryotic polymerases such as the beta-chain subunits of
Escherichia coli (E.

coli)

and Saccharomyces cerevisiae RNA

polymerase, respectively (Roy et al., 1988).
cell lysate of Spodoptera frugiperda

By using the

(SF) cells infected

with a recombinant baculovirus expressing the VP1 protein,
labeled ATP was incorporated into the poly(U)-templates,
indicating that VP1 is a potential BTV RNA polymerase
(Urakawa et al., 1989).

However, there is no report of

using purified BTV VP1 for the polymerase activity assay,

8

yet.

Recently,

four of the linear epitopes were mapped at

amlno acid residues #42-55, #459-473, #881-903, and #12511274 (Huang et al., 1995) using oligoclonal antibodies
produced in rabbits.
VP2 protein

VP2 protein 1s a maJor component of the outer capsid
of BTV.

It is the serotype-specific antigen, and can

elicit neutralizing antibodies
Kahlon et al., 1983).

(Huismans and Erasmus, 1981;

It is also the protein responsible

for the hemagglutination of red blood cells (Cowley and
Gorman, 1987).

The segment coding for VP2 is the L2 gene

(Verwoerd et al., 1972).

The lengths of L2 genes of the

five US BTVs are slightly different; 2943 bp in BTV-2
(Yamaguchi et al., 1988), 2923 bp in BTV-17, 2935 bp ln
BTV-13, and 2926 bp in both BTV-10 and -11
1985) .

(Purdy et al.,

The molecular weight of VP2 is about 111 kDa, and

there are 180 copies of VP2 per virion, calculated by
cryoelectron microscopy (Hewat et al., 1992).

The deduced

amino acid sequences of VP2 vary considerably among all
serotypes.

Peptide mapping is further evidence that VP2 1s

unique for each of the US serotypes (Mecham et al., 1986).
However, each has a highly conserved carboxyl terminus,
middle region between amino acid #360-367 (NPYPCLRG), and
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six conserved cysteines.

These conserved regions may be

responsible for VP2 maintaining its overall structure or
may be required for interactions with other viral proteins.
The residue variability for cognate VP2 reflects the role
of this protein in serotype-specific neutralizing antibody
production.

VP2 purified from SDS-PAGE was not able to

elicit neutralizing antibodies.

However, recombinant VP2

expressed in insect cells was able to produce neutralizing
antibodies (Inumaru and Roy, 1987), indicating that the
neutralizing epitopes could be conformational.

Hwang and

Li (1993) have mapped some of the potential neutralization
epitopes of BTV-2 (amino acid residues #397-408 and #428442), BTV-10 (amino acid residues #199-213 and #248-265),
BTV-11

(amino acid residues #82-94 and #310-321), and BTV

17 (amino acid residues #31-43 and #444-464).
VP3 protein

VP3 protein is one of the major inner core proteins.
It is encoded by the L3 gene (2772 bp in length) and is
highly conserved among serotypes (Hwang et al., 1994).

It

_has been shown to contain a serogroup-specific antigen
(Huismans and Erasmus, 1981), similar to VP7.

From the

analysis of the deduced amino acid sequences, VP3 has a low
content of charged amino acids and a high content of
hydrophobic amino acids (Hwang et al., 1994).

The
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molecular weight of VP3 is about 103 kDa with a pi of 6
(Hwang et al., 1994), and there are 120 copies of VP3 per
Vlrlon (Burroughs et al., 1995).

It exists as a dimer that

forms a scaffold upon which the trimers of VP7 reside.
When VP3 and VP7

(the two major lnner core proteins) were

co-expressed in a baculovirus expression system, the
formation of a viral core-like particle (CLP) was found
(French and Roy, 1990).

It was concluded that the assembly

of the inner core does not require the presence of other
viral proteins nor the whole viral genome (French and Roy,
1990) .

The methionine at residue #500 and the arginine at

residue #502 of VP3 were found to oe required for the CLP
formation (Tanaka and Roy, 1994).

The CLP formed by VP3

and VP7 was shown to bind BTV and non-BTV single-stranded
RNA (ssRNA) and also DNA.

The binding activity was shown

to reside on VP3 (Loudon and Roy, 1992).
VP4 protein

VP4 is one of the mlnor lnner core proteins.
estimated

An

5 to 10 molecules are present per virion

(Huismans and Van Dijk, 1990).
this protein ls about 75 kDa.

The molecular weight of
The segment encoding VP4 lS

the M1 gene. It has the shortest 5'-noncoding region among
all BTV genes.

Hybridization studies indicated that the

sequences among BTV are highly conserved.

VP4 of BTV-10
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has a high content of charged amlno acids (Yu et al.,
1987), which is common in many of the nucleic acid binding
proteins.

The function of VP4 is still unknown.

In a

recent study (Le Blois et al., 1992), VP4 has exhibited
GTP-binding activity in both purified virions and cell
lysate containing recombinant VP4 expressed ln a
baculovirus expression system.

The 5' ends of the mRNAs of

BTV are believed to be capped and methylated during
transcription, like reovirus and rotavirus; however, it has
never been experimentally demonstrated.

Due to the GTP-

binding activity of VP4, it is the prime candidate for the
guanylyltransferase of BTV.

VPS Protein
The segment coding for VPS protein lS the M3 gene
which has 1638 bp, with an open reading frame that can code
for 526 amino acids.

The molecular weight of this protein

is about 59 kDa (Purdy et al., 1986; Hirasawa and Roy,
1990; Oldfield et al., 1991; Yang and Li, 1992).

Along

with VP2, VPS is another major outer capsid protein of BTV.
VPS is the only structural protein that is glycosylated
(Yang and Li, 1993) . It was shown that VPS can bind to
different types of lectins including Galanthus nivalis
agglutinin (GNA), Sambucus nigra agglutinin (SNA), Peanut
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agglutinin (PNA), and Datura stramonium agglutinin (DSA)
but not Maackia amurensis agglutinin (MAA) .
The functions of VP5 have not been determined.

From

the deduced amino acid sequence analyses of the M3 gene, we
know that VP5 is very variable (Yang and Li, 1992), but not
as variable as the VP2 protein.

VP5 is enriched with non-

polar amino acids (such as isoleucine and alanine).

Unlike

the VP2 protein, the VP5 protein cannot elicit
neutralization antibodies against BTV (Marshall and Roy,
1990) even though it is located in the outer capsid.
However, Huismans et al.

(1983) showed that a mixture of

VP2 and VP5 induced a higher titer of the neutralizing
antibodies than VP2 alone.
Two antigenic epitopes of VP5 were mapped (Yang et
al.,

1992b).

One linear epitope was identified between

amino acid residues #175-189.

This epitope is common and

conserved ln all five US BTV serotypes.

The other epitope

was found to be conformational and located between amlno
acid residues #33 to #215.
VP6 protein

VP6 is one of the mlnor lnner core proteins with a
molecular weight of 35 kDa (Roy et al., 1990; Hwang et al.,
1992b).

It is encoded by the S3 gene, which is 1049 bp in
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length (Fukusho et al., 1989; Hwang et al., 1992b).

There

are approximately 37 copies of VP6 per virion (Huismans and
van Dijk, 1990).

The sequences of S3 genes among BTVs are

highly conserved (Hwang et al., 1992b).

A single, long ORF

of the S3 gene is identified in all five US BTVs (Hwang et

al., 1992b).

This ORF encodes a 325-amino acid VP6 of ETV-

10, -11, -13, and -17.

However, the ORF coding for BTV-2

VP6 is only 301 amino acids in length, which is 24 amino
acids shorter than others.

This is due to a shift of an

initiation codon from nucleotides #28-30 to #100-102.
Sequence analyses of VP6 have revealed a common motif for a
helicase.

The helicase activity may be involved in

unwinding the dsRNA genome for the mRNA synthesis.
However, no such activity has yet been found and reported.
Hayama and Li (1994) mapped six linear antigenic
epitopes of VP6 at amino acid residues #35-46,
#181-193, #200-209, #216-227, and #292-302.

#63-78,

Four

additional conformational epitopes were mapped recently
(Hayama and Li, manuscript in preparation).
are conserved among all five US BTVs.

These epitopes

By using recombinant

VP6 expressed in E.coli, Hayama and Li (1994 and manuscript
in preparation) have identified the nucleic acid binding
activity and domains of VP6. ·

It has been shown that VP6

binds to ssRNA, ssDNA, dsRNA, and dsDNA.

Two domains
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responsible for dsDNA and dsRNA-binding are mapped at amlno
acid residues #181-209 and #292-302 near the carboxyl
terminus.

Domains for the ssRNA- and ssDNA-binding were

also mapped at the same two locations (Hayama and Li,
manuscript in preparation) .
VP7 protein

VP7 is the maJor lnner core protein, with a molecular
weight of 38 kDa.
core proteins

The protein comprises 36% of the total

(Huismans et al., 1987c).

specific antigenic determinants
1981; Gurnm and Newman, 1982).

It has serogroup-

(Huismans and Erasmus,
The segment coding for VP7

is the S1 gene, which is 1156 bp in length.

The S1 gene

has an ORF capable of coding for 349 amino acid residues.
The sequences of S1 genes and the deduced amino acid
sequence for each VP7 are highly conserved among all five
US BTVs.

Only a single lysine residue is located at amlno

acid residue #255 in VP7, determined from the deduced amino
acid sequence.

By using endoproteinase lys-e to digest all

five US BTVs VP7 proteins, the presence of this single
lysine residue of VP7 was confirmed (Li and Yang, 1990) .
VP7 is very hydrophobic, reflecting its location and
interior preference.

However, Hyatt and Eaton (1988) and

Lewis and Grubman (1990)

showed that monoclonal antibodies

against VP7 reacted with intact virions, and concluded that
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a portion of the VP7 extrudes to the surface of the BTV
virion.

Si~ilar

results were obtained by immunoelectron

microscopy (Eaton et al., 1991).

VP7 was clearly shown to

be myristylated when BTV was purified from infected BHK-21
cells containing

3

H-myristic acids in the medium (Huang and

Li, unpublished observation) .

It seems that VP7 is the

only major myristylated structural protein of BTV. The
significance of this posttranslational modification is
still unknown.
Five linear antigenic epitopes were mapped at amino
acid residues #1-60, #207-240, #256-275, #339-349, and
#122-139 (Li and Yang, 1990; Wang et al., 1996).

These

epitopes were highly conserved among the VP7 proteins of
all five US BTVs.

In addition to the linear epitopes, one

conformational and potential serogroup-specific
immunodominant epitope was identified at the N-terminus of
VP7 proteins between amino acid residue #30 and 48

(Wang et

al. , 19 94) .
VP7 proteins exist in the inner core as trimers
copies per virion) .

(780

Recently, VP7 was crystallized and

analyzed at 2.6A resolution.

In this study it was shown

that VP7 consists of two domains, one aB-sandwich, the
other a bundle of a-helices, and a short carboxy-terminal
arm (Grimes et al., 1995).

The carboxy-terminal arm is
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predicted to tie the trimers together during capsid
formation.

A new study has shown that VP7 proteins are

orientated with their N-terminus accessible on the surface
of the intact virion by immunoelectron microscopy (Wang et

al., 1996), although VP7 is one of the major inner core
proteins.
NSl protein

There are four nonstructural proteins found in BTVinfected cells.

NS1 and NS2 are the two major non-

structural proteins, whereas NS3 and NS3A are barely
detectable. NS1 protein is synthesized in large amounts and
represents about 25% of the total virus-specified protein
in infected cells.

It forms high molecular weight tubular

structures (Huismans, 1979; Huismans and Els, 1979) .

These

tubules are formed in the cytoplasm of BTV-infected cells
as early as 4 hr postinfection (Huismans, 1979) and before
the formation of the significant amounts of virus inclusion
bodies

(VIBs) and viral progeny (Hyatt et al., 1989).

From

electron microscopic studies of BTV-infected cells it was
evident that these tubules accumulate late in infection,
particularly in peri-orjuxtonuclear locations.

The segment

coding for NS1 is the M2 gene, which is 1769 bp in length
(Lee and Roy, 1987; Grubman and Samal, 1989; Wang et al.,
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1989; Hwang et al., 1993).

This gene has an ORF with a

coding capacity of 552 amino acids (64 kDa).
analyses,

the

nucleoti~e

From sequence

sequence identity of M2 genes

among five US BTVs is between 92 to 99%; the deduced amino
acid sequence identity of NS1 is between 96-99%

al., 1993).

(Hwang et

NS1 is rich in cysteine residues, and all 16

cysteines are conserved in the cognate NS1 proteins of
different BTV serotypes.

This indicates the probability

that NS1 may have highly ordered disulfide bonds.
Two cysteines (amino acid residues #337 and 340)
located in a hydrophilic region of NS1 were found to be
required for tubule polymerization (Monastyrskaya et al.,
1994).

In addition to these two cysteines, the first 10

amino acids in the amino-terminus and the 20 amino acids 1n
the carboxy-terminus are also required for the tubule
polymerization in insect cells that were infected by
baculovirus expressing recombinant NS1

al., 1994).

(Monastyrskaya et

The mutated NS1 proteins in the infected

insect cells made ribbon-like structures instead of tubular
polymers.
Eaton et al.

(1987)

reported that NS1 was detected in

cytoskeleton-associated virus particles, purified virions,
and core particles; and suggested that viral morphogenesis
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of BTV may proceed ln this tubular structure composed of
NS1.

NS2 Protein
NS2 protein lS the nonstructural protein that forms
VIEs in the cytoplasm of BTV-infected cells.

It is the

only BTV protein that lS phosphorylated (Huismans et al.,
1987b; Devaney et al., 1988).

The segment that encodes for

NS2 is the S2 gene, which contains 1125 nucleotides

(Yang

et al., 1992a) with an ORF coding for 354 amlno acid
residues.

The molecular weight of NS2 is about 41 kDa from

the deduced amino acid sequence.

The protein lS

hydrophilic and rich in charged amino acids.

Two of the

linear antigenic epitopes were mapped at amino acid
residues #153-166 (DIRELRQKIKNERE) and #274-286
(EKVAKQIKLKDER)

(Huang and Li, unpublished observation) .

NS2 from BTV-infected cells (Huismans et al., 1987b),
recombinant NS2 ·expressed in insect cells (Thomas et al.,
1990), and recombinant NS2 expressed in E. coli

(Li et al.,

unpublished observation) has the ability to bind BTV mRNA
and non-BTV ssRNA but not dsRNA.

The potential function of

NS2 lS the selection and condensation of the BTV mRNAs
during viral morphogenesis.
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The ssRNA-binding activity of the NS2 protein has been
intensively studied.

Recently, the ssRNA-binding domains

of the NS2 protein were identified at the amino terminus
(Zhao et al., 1994).

Point-~utational

studies indicated

that the arginines at amino acid residues #6 and #7 and the
lysine at residue #4, but not the glutamic acid at residue
#2, are involved in ssRNA-binding.

However, in our

laboratory, there are another three potential ssRNA-binding
domains that have been mapped at amino acid residues #2-11,
#153-166, and #274-286 (unpublished observation) .

By

deletion it has been shown that neither the amino- nor
carboxy-terminus of NS2 is involved in VIB formation (Zhao
e t al. , 19 9 4) .
NS3/3A Protein

The other nonstructural proteins of BTV are NS3 and
NS3A.

Both proteins are synthesized in small amounts and

at the late infection stage.

Both of them are encoded by

the smallest segment of BTV dsRNA, the S4 gene (Mertens et

al., 1984; Van Dijk and Huismans, 1988).

The S4 gene is

·822 bp in length and has two long, in-phrase open reading
frames

(Hwang et al., 1992a).

The in vitro translation products of S4 mRNA contain
two proteins, NS3 and NS3A, with a molecular weight of 28
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and 25 kDa, respectively.

The two proteins are produced by

the two in-phase ORFs of the S4 gene.

The two proteins

have almost identical peptide maps and are synthesized 1n
very small amounts in BTV-infected cells (Van Dijk and
Huismans, 1988).

After the first AUG was qeleted, only

NS3A was synthesized but NS3 was not synthesized (Wu et
al.,

1992).

From the deduced amino acid sequences of NS3,

at least two conserved hydrophobic domains at amino acid
residues #118-147 and #156-182 among all five US BTVs may
represent transmembrane domains.

Hyatt et al.

(1991),

using immunoelectron microscopic studies, reported that NS3
and NS3A are associated with intra-cellular, smoothsurfaced vesicles, and with the plasma membrane.
In a recent study by Wu et al.

(1992), NS3 and NS3A

were identified as N-linked glycoproteins containing highmannose sugars such as polylactosaminoglycans.

In this

study it was also suggested that the carbohydrate chains
are not required for the NS3 to be transported to the cell
surface.
The function(s) of NS3 and NS3A are still unknown.

A

hypothesis is that they are involved in the release of BTV
from infected cells during the final stages of BTV
morphogenesis.
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Viral replication
BTV replicates in the cytoplasm of infected cells and
infection finally leads to cell death.

The mechanism of

BTV replication is still largely unknown.

BTV is taken up

by endocytosis after attachment to cells (Lecatsas, 1968;
cromack et al., 1971).

The binding of BTV to cells is

mediated by the outer capsid protein VP2 (Huismans et al.,
1983).

However, the viral receptor has not been

identified.

The virus adsorbs to

~usceptible

cells within

20 min at both 4° C and 37°C (Huismans et al., 1983).

This

suggested that the membrane fluidity of the infected hosts
is not involved in the entry of BTV.

The outer coat

protein VP2 is then removed in endosomes within 1 hr of
infection (Huismans et al., 1987c).

VPS is probabiy

removed at the same location, also prior to release of the
core particle into the cytoplasm.

The release of virus

from endosomes is dependent on the low pH within this
organelle.

Increasing the pH of endosomes by adding NH4Cl

and methylamine (weak bases} inhibited the entry of
endocytosed virus particles into the cytoplasm (Ohkuma and
Poole, 1978).

In the cytoplasm, core particles of BTV bind

to intermediate filaments (Eaton et al., 1987; Eaton and
Hyatt, 1989) and transcribe virion mRNAs (Bowne and Jochim,
1967 ) ·

The transcriptase activity of virions requires the
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removal of both outer capsid proteins (VP2 and VP5)
Dijk and Huismans, 1980).

Th~

(Van

mRNA species are synthesized

at different rates (Huismans and Verwoerd, 1973).

The NS1

mRNA seems to be the most abundant in the early stage of
infection.

Huismans et al.

(1987c) suggested that the

transcriptase activity of the core particle may be active
for a limited time, and unlike reovirus, core particles do
not reassociate with newly synthesized outer coat proteins
to release from cells as progeny virus.

Translation then

occurs, using the newly transcribed mRNAs.

The generated

viral proteins appear to condense with single strand-RNAs
(ssRNAs) to form core-like particles, which ultimately
aggregate to generate viral inclusion bodies (VIBs).

The

new viral core particles are made within the VIB matrix
(Hyatt et al., 1989).

Complementary RNAs will then be

synthesized using the plus-sense RNAs as templates to
complete the formation of dsRNAs.

By studying the s1ze and

density of the particles, it has been suggested that the
particles leaving the VIB contain dsRNAs; therefore, BTV
replicase may be found within the VIB.

A portion of the

outer coat proteins is added to the core particles and the
remainder may follow when the virus leaves the VIBs.

The

morphogenesis of BTV occurs within the VIBs, and a high
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proportion of viral progeny remains associated with cell
debris

(Howell and Verwoerd, 1971).

Diagnosis of bluetongue
disease
The clinical diagnosis of bluetongue disease in sheep
is uncomplicated for an experienced clinician (Gibbs,
1983) .

The diagnosis of this disease in cattle is often

clinically unnoticeable, and it is very easily confused
with other diseases such as malignant cattarhal fe.v er and
bovine virus diarrhea/mucosal disease.

Isolation of BTV

from infected animals is difficult for diagnosis.
Detection of antibodies to BTV is based on group-reactive
tests (including complement-fixation, ELISA, fluorescentantibody, etc.) and the serotype-specific neutralization
tests (Pearson et al., 1985).

In a recent report it was

indicated that competitive enzyme-linked irnrnunosorbent (CELISA) can be used as a rapid and specific test for
serodiagnosis of BTV infection in llamas and other wild
ruminants (Afshar et al., 1995).
The most common antigens used for detecting BTV
antibodies in infected animals are NS1

(Urakawa and Roy,

1988; He et al., 1991) and VP7 (Lunt et al., 1988).
study done by He et al.

In the

(1991), sheep anti-NSl antibodies

were raised with the recombinant NS1 expressed in E. coli
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and used to detect the NSl proteins of the five US BTVs.
The immunological activity of the antibody was
indistinguishable between native and recombinant NSl.

This

i ndicated that NS1 can be used as a group-specific antigen
ln the diagnosis of BTV infections, in addition to VP7.
New techniques have been developed for the detection
of BTV in biological specimens.

These methods include

polymerase chain reaction (PCR) and nucleic acid
hybridization (Wade-Evans et al., 1990; Venter et al.,
1991).

Wade-Evans et al.

(1990) used a group of primers

designed complementary to the termini of the 10 dsRNAs of
South Africa BTV serotype 1 (BTV-1SA) to amplify each
individual segment.

They found that the S1 gene gave the

best amplification results.

This primer was able to

amplify the S1 gene from red blood cells (RBC) and buffy
coat samples from cattle which were infected with BTV-4.
Venter et al.

(1991) also determined the genomic probes of

BTV that can give the best sensitivity to detect BTVspecified RNA in infected cells.

They found that the probe

derived from the genome segment that encodes NS1

(M2 gene)

to be the most sensitive. It could detect BTV-specified RNA
ln cells as early as two to three hr postinfection, and it
could also be used to analyze the cells infected at very
low multiplicities of infection (M.O.I.).

The great
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sensitivity of this probe is due to M2 mRNA, the target of
the probe, which is transcribed more frequently than other
viral mRNAs.

Similar types of experiments were also shown

in epizootic hemorrhage disease virus
encephalitis virus

(EHDV) and

(EEV).

Vaccine development
Development of a vaccine against BTV took place as
early as 1908 (Theiler, 1908).

This was accomplished by

immunizing sheep with an attenuated strain of BTV that had
been serially passaged in sheep.

Chemically inactivated

viruses were also used for the vaccination.
these have been shown unsafe and unsuccessful

Unfortunately,
(Neitz, 1948;

Mahrt and Osburn, 1986a; Mahrt and Osburn, 1986b) due to
the capability of the viruses to reassort in mixed
infections.
Huismans et al.

(1987a) had shown that purified VP2

alone could elicit neutralizing antibodies against BTV and
protect the animal challenged with the same serotype BTV.
Inumaru and Roy (1987) and Marshall and Roy (1990) used
recombinant BTV neutralizing antigen(s)

expressed in insect

cells to produce neutralizing antibodies against BTV.
However, these types of approaches are expensive and only
protect the homologous but not heterologous BTV serotypes.
Another approach has been investigated using synthetic
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peptides as subunit vacclne.

Synthetic peptide vaccine has

the advantages of being inexpensive, stable, and can
produce high titer antibodies.

If a common neutralization

epitope of BTV serotypes is identified, it can be used as a
subunit vaccine to protect animals from all BTV serotypes.
JUSTIFICATION AND OBJECTIVES

Unlike reovlrus, the replication of BTV is still not
clear.

Many of the assumptions regarding mRNA synthesis

and genomic RNA replication are based on information
obtained from reovirus research.

After the outer coat

proteins are removed from the virion, the transcriptase lS
activated and transcribes mRNAs uslng the dsRNA genome
segments as templates (Van Dijk and Huismans, 1980; Martin
and Zweerink, 1972).
to viral proteins.

The mRNAs are capped and translated
The mRNAs are also used as templates

for synthesizing negative-sense RNAs to form the dsRNA
genome.

All 10 segments of dsRNA are always sorted in a

single virion.

These characteristics of BTV transcription

and replication are considered to be the functions of the
lnner core minor proteins.

However, the functions of the

lnner core proteins are still unknown.

To understand these

phenomena, each of the inner core proteins has to be
characterized, and their functions have to be identified.
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VPl expressed as a recombinant protein in the
baculovirus expression system_ has a potential RNA
polymerase activity.

It might be an RNA-dependent RNA

polymerase of BTV (Urakawa et al. 1989).

VP6 recently has

been characterized as a nucleic acid binding protein
(Hayama and Li, 1994 and manuscript in preparation) .
has a nonselective nucleic acid binding activity

~n

It

vitro.

VP4, a minor component in the inner core of BTV, 1s encoded
by the M1 gene.

Huismans (1979) suggested that only 5 to

10 molecules of VP4 are present in each virion.
little information is known about the function(s)
characteristics of VP4.

Very
and

The only information known

regarding the function of VP4 is that both viral and
recombinant VP4 expressed in a baculovirus expression
system have GTP-binding activity (Le Blois et al., 1992).
VP4 1s potentially a guanylyltransferase of BTV.
The objective of my study is to investigate the
function of VP4.

I will determine the nucleic acid

sequence of the M1 gene that codes for VP4.

Based on the

deduced amino acid sequence, I plan to locate some of the
potential functional motifs of VP4 by comparing its amino
acid sequence with other known sequences and to perform
structural and functional analysis of these domains.

This

information will reveal the potential role(s) of VP4 1n
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vlrus replication and morphogenesis.

I will also compare

the VP4 sequences of five US BTV serotypes to identify the
conserved and probably essential domains of VP4 which may
be required for its function.
In our laboratory we have determined the genetic
relationships among BTV serotypes

(Kowa~ik

and Li, 1989;

Kowalik et al., 1990; Hwang et al., 1992a; Hwang et al.,
1992b; Yang and Li, 1992; Yang et al., 1992a; Hwang et al.,
1993; Hwang et al., 1994; Huang et al., 1995).

Sequencing

the M1 genes of all five US BTV serotypes will produce
further information for phylogenetic analysis of the US BTV
serotypes.
Because only a small amount of VP4 is present in the
Vlrus, it is very difficult, costly, and time-consuming to
obtain this protein from the purified virus and elucidate
its potential function(s).

Recombinant VP4 will be used in

this study.
The specific alms of this study are:
(1) To clone and determine the nucleotide sequences of
the M1 gene that codes for VP4 of five US BTV serotypes.
(2)

To compare the phylogeny of five US BTV serotypes

by analyzing their five M1 gene sequences.
(3) To express and puri .f y recombinant VP4.
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(4) To map and characterize some of the functional
domainE of VP4.
REFERENCES

Afshar, A., Heckert, R.A., 8 ulac, G.C., Trotter, H.C., and
Myers, D.J. (1995). Application of a competitive ELISA
for the detection of bluetongue virus antibodies in
llamas and wild ruminants. J. Wildlife Disease 31, 327330.
Barber, T.L. (1979). Temporal appearance, geographic
distribution, and species of origin of bluetongue
serogroups in the United States. Am. J. Vet. Res. 40,
1654-1656.
Borden, E.C., Shope, R.E., and Murphy, F.A. (1971).
Physiochemical and morphological relationship of some
arthropod-borne viruses to bluetongue virus--a new
taxonomic group: Physiochemical and serological studies.
J. Gen. Virol. 13, 261-271.
Bowne, J.G., and Jochim, M.M. (1967). Cytopathologic change
and development of inclusion bodies in cultured cells
infected with bluetongue virus. Am. J. Vet. Res. 28,
1091-1105.
Burroughs, J.N., Grimes, J.M., Mertens, P.P.C., and Stuart,
D. I. (1995). Crystallization and preliminary X-ray
analysis of the core particle of bluetongue virus.
Virology, 210, 217-220.
Cowley, J.A., and Gorman, B.M. (1987). Genetic
reassortments for identification of the genome segment
coding for the bluetongue virus haemagglutinin. J Virol.
61, 2304-2306.
Cromack, A.S., Blue, J.L., and Gratzek, J.B. (1971). A
quantitative ultrastructural study of the development of
bluetongue virus in Madin-Darby bovine kidney cells. J.
Gen. Virol. 13, 229-244.
Devaney, M.A., Kendall, J., and Grubman, M.J. (1988).
Characterization of a non-structural phosphoprotein of
two orbiviruses. Virus Res. 11, 51-164.

30
Eaton, B.T., Gould, A.R., Hyatt, A.D., Coupar, B.E.H.,
Martyn, J.C., and White, J.R. (1991). A bluetongue
serogroup-reactive epitope in the amino terminal half of
the major core protein VP7 is accessible of the surface
of bluetongue virus particles. Virology 180, 687-696.
Eaton, B.T., and Hyatt, A.D. (1989). Association of
bluetongue virus with the cytoskeleton. Subcell Biochem.
15, 229-269.
Eaton, B.T., Hyatt, A.D., and White, J.R. (1987).
Association of bluetongue virus with the cytoskeleton.
Virology 157, 107-116.
Erasmus, B.J. (1975). Bluetongue 1n sheep and goats. Aust.
Vet. J. 51, 165-170.
Evans-Wade, A.M., Mertens, P.P.C., and Belsham, G.J.
(1992). Sequence of genome segment 9 of bluetongue v1rus
(serotype 1, South Africa) and expression analysis
demonstrating that different forms of VP6 are derived
from initiation of protein synthesis at two distinct
sites. J. Gen. Virol. 73, 3023-3026.
French, T.J., and Roy, P. (1990). Synthesis of empty BTV
core particles by a recombinant baculovirus expressing
the two major structural core proteins. J. Virol. 64,
1530-1536.
Fukusho, A., Yu, Y., Yamaguchi, Y., and Roy, P. (1989).
Completion of the sequence of bluetongue virus serotype
10 by the characterization of a structural protein, VP6,
and a non-structure protein, NS2. J. Gen. Virol. 70,
1677-1689.
Geering, W.A. (1975). Control of bluetongue in an epizootic
situation: Australian plans. Aust. Vet. J. 51, 220-224.
Gibbs, E.P.J.
13.

(1983). Bluetongue disease. Agripractice 4,

Grimes J., Basak A.K., Roy P~, and Stuart D. (1995). The
crystal structure of bluetongue virus VP7. Nature 373,
167-170.
Grubman, M.J., Appleton, J.A., and Letchworth, G.J. (1983).
Identification of bluetongue virus serotype 17 genome
segments coding for polypeptides associated with virus

31
neutralization and intergroup reactivity. Virology 131,
353-366.
Grubman, M.J., and Samal, S.K. (1989). Nucleotide and
deduced amino acid sequence of the nonstructural protein
NS1, of the US bluetongue virus serotype 17. Nucleic
Acids Res. 17, 10498.
Gumm, I.D., and Newman, J.F.E. (1982). The preparation of
purified bluetongue virus group antigen for use as a
diagnostic reagent. Arch. Virol. 72, 83-93.
Hayama, E., and Li, J.K.-K. (1994). Mapping and
characterization of antigenic epitopes and the nucleic
acid binding domains of the VP6 protein of bluetongue
viruses. J. Virol. 68, 3604-3611.
He, X.S., Wang, L.F., Doi, R.H., Maid, M., Osburn, B.I.,
and Chuang, R.Y. (1991). Expression of a full-length
nonstructural protein NS1 of bluetongue virus serotype
17 in Escherichia Coli.
Biochem. Biophys. Res. Commun.
180, 994-1001.
Hewat, E.A., Booth, T.F., Wade, R.H., and Roy, P. (1992).
Structure of bluetongue virus particles by cryo-electron
microscopy. J. Struct. Biol. 109, 1-69.
Hirasawa, T., and Roy, P. (1990). The complete nucleotide
sequence of VP5 of a strain of bluetongue virus of
serotype 2 isolated in the USA reveals is close relation
with a virus of serotype 1 isolated in Australia. Virus
Res. 15, 107-112.
Howell, P.G., and Verwoerd, D.W. (1971). Bluetongue virus.
In: African swine fever virus and bluetongue virus (W.R.
Hess, P.G. Howell, and D.W. Verwoerd, eds.), pp. 35-74.
Springer, Berlin.
Huang, I-J., Hwang, G.-Y., Yang, Y.-Y., Hayama, E., and Li,
J.K.-K. (1995). Sequence analyses and antigenic epitope
mapping of the putative RNA-directed RNA polymerase of
five US bluetongue viruses. Virology 214, 280-288.
Huismans, H. (1979). Protein synthesis in bluetongue virusinfected cells. Virology 92, 385-396.

32
Huismans, H., and Els, H.J. (1979). Characterization of the
microtubules associated with the replication of three
different orbiviruses. Virology 92, 397-405.
Huismans, H., and Erasmus, B.J. (1981). Identification of
the serotype-specific and serogroup-specific antigens of
bluetongue virus. Onderstepoort J. Vet. Res. 48, 51-58.
Huismans, H., Vander Walt, N.T., Cloete, M., and Erasmus,
B. J. ( 198 3) . The biochemical and immunological
characterization of bluetongue virus outer capsid
polypeptides. In: Double-stranded RNA viruses (R.W.
Compans and D.H.L. Bishop, eds.), pp. 165-172. Elsevier,
New York.
Huismans, H., Vander Walt, N.T., Cloete, M., and Erasmus,
B. J. ( 1987a) . Isolation of a capsid protein of
bluetongue virus that induces a protective lmmune
response in sheep. Virology 157, 172-179.
Huismans, H., and Van Dijk, A.A. (1990). Bluetongue virus
structural components. Curr. Top. Microbial. Immunol.
162, 21-3 7.
Huismans, H., Van Dijk, A.A., and Bauskin, A.R. (1987b). In
vitro phosphorylation and purification of a
nonstructural protein of bluetongue virus with affinity
for single~stranded RNA. J. Virol. 61, 3589-3595.
Huismans, H., Van Dijk, A.A., and Els, H.J. (1987c).
Uncoding of parental bluetongue virus to core and
subcore particles ln infected L cells. Virology 157,
180-188.
Huismans, H., and Verwoerd, D.W. (1973). Control of
transcription during the expression of the bluetongue
virus genome. Virology 52, 81-88.
Hwang, G.-Y., Yang, Y.-Y., Chiou, J.-F., and Li, J.K.-K.
(1992a). Sequence conservation among the cognate
nonstructural NS3/3A protein genes of six bluetongue
viruses. Virus Res. 23, 151-161.
Hwang, G.-Y., Yang, Y.-Y., Chiou, J.-F., and Li, J.K.-K.
(1992b).
Comparative sequences analyses of the cognate
structural protein VP6 genes of five US bluetongue
viruses. Virus Res. 24, 315-323.

33
Hwang, G.-Y., and Li, J.K.-K. (1993). Identification and
localization of a serotypic neutralization determinant
on the VP2 protein of bluetongue virus 13. Virology 195,
859-862.
Hwang, G.-Y., Chiou, J.-F., Yang, Y.-Y., and Li, J.K.-K.
(1993). High-sequence conservation among the United
States bluetongue viruses cognate M2 genes which encode
the nonstructural NS1 tubule protein. Virology 192, 321327.
Hwang, G.Y., Xiang, M., and Li, J.K.-K. (1994). Analyses
and conservation of sequences among the cognate L3
segments of the five United States bluetongue viruses.
Virus Res. 32, 381-389.
Hyatt, A.D., and Eaton, B.T. (1988). Ultrastructural
distribution of the major capsid proteins within
bluetongue virus and infected cells. J. Gen. Virol. 69,
805-815.
Hyatt, A.D., Eaton, B.T., and Brookes, S.B. (1989). The
release of bluetongue virus from infected cells and
their superinfection by progeny virus. Virology 173, 2134.
Hyatt, A.D., Gould, A.R., Coupar, B., and Eaton, B.T.
(1991). Localization of the non-structural protein NS3
in bluetongue virus-infected cells. J. Gen. Viol. 72,
2263-2267.
Inumaru, S., and Roy, P. (1987). Production and
characterization of neutralization antigen VP2 of
bluetongue virus serotype 10 using a baculovirus
expression vector. Virology 157, 472-479.
Kahlon, D.L., Sugiyama, K. and Roy; P. (1983). Molecular
bases of bluetongue virus neutralization. J. Virol. 48,
627-632.
Karabatsos, N. (1985). International catalogue of
orbiviruses including certain other viruses of
vertebrates, 3rd ed. The American Society of Tropic
Medicine and Hygiene, San Antonio, Texas.
Kowalik, T.F., and Li, J.K.-K. (1989). Sequence analyses
and structural predictions of double-stranded RNA
segment S1 and VP7 from United States prototype

34
bluetongue virus serotypes 13 and 10. Virology 172, 189195.
Kowalik, T.F., Yang, Y.-Y., and Li, J.K.-K. (1990).
Molecular cloning and comparative sequence analyses of
bluetongue virus S1 segments by selective synthesis of
specific full-length DNA copies of dsRNA genes. Virology
177' 820-823.
Le Blois, H., French, T., Mertens, P.P.C., Burroughs, J.N.,
and Roy, P. (1992). The expressed VP4 protein of
bluetongue virus binds GTP and is the candidate guanylyl
transferase of virus. Virology 189, 757-761.
Lecatsas, G. (1968). Electron microscopic study of the
formation of bluetongue virus. Onderstepoort J. Vet.
Res. 35, 139-149.
Lee, J., and Roy, P. (1987). Complete sequence of the NS1
gene (M6 RNA) of US bluetongue virus serotype 10.
Nucleic Acids Res. 15, 7207.
Lewis, S.A., and Grubman, M.J. (1990). Bluetongue v1rus:
Surface exposure of VP7. Virus Res. 16,7-26.
Li,

J.K.-K., and Yang, Y.-Y. (1990). Mapping to two
immunodominant antigenic epitopes conserved among the
major inner capsid protein, VP7 or five US bluetongue
viruses. Virology 178, 552-559.

Loudon, P.T., and Roy P. (1992). Interaction of nucleic
acids with core-like and subcore-like particles of
bluetongue virus. Virology 191, 231-236.
Luedke, A.J., Jochim, M.M., and Jones, R.H. (1977).
Bluetongue in cattle: Effects on calves previously
infected in utero. Am. J. Vet. Res. 37, 1701-1704.
Lunt, R.A., White, J.R., and Della-Porta, A.J. (1988).
Studies with enzyme-linked immunosorbent assays for the
serodiagnosis of bluetongue and epizootic haemorrhagic
disease of deer. Vet. Microbial. 16, 323-338.
Mahrt, C.R., and Osburn, B.I. (1986a). Experimental
bluetongue infection of sheep; effect of vaccination:
Clinical and immunological studies. Am. J. Vet. Res. 47,
1191-1197.

35
Mahrt, C.R., and Osburn, B.I. (1986b). Experimental
bluetongue infection of sheep; effect of vaccination:
Pathologic, immunofluorescent, and ultrastructural
studies. ·Am. J. Vet. Res. 47, 1198-1203.
Marshall, J.J.A., and Roy, P. (1990). High level expression
of the two outer capsid proteins of bluetongue virus
serotype 10: Their relationship with the neutralization
of virus infection. Virus Res. 15, 189-196.
Martin, S.A., and Zweerink, H.J. (1972). Isolation and
characterization of two type of bluetongue v1rus
particles. Virology 50, 495-506.
Mecham, J.O., Dean, V.C., and Jochim, M.M. (1986).
Correlation of serotype specificity and protein
structure of the five US serotypes of bluetongue
viruses. J. Gen. Viral. 67, 2617-2624.
Mertens, P.P.C., Brown, F., and Sanger, D.V. (1984).
Assignment of the genome segments of bluetongue virus
type 1 to the proteins which they code. Virology 135,
207-217.
Mertens, P.P.C., Burroughs, J.N., and Anderson, J. (1987).
Purification and properties of virus particles,
infectious subviral particles, and core of bluetongue
v1rus serotype 1 and 4. Virology 156, 375-386.
Metcalf, P.M., Cyrklaff, M., and Adrian, M. (1991).
The
three dimensional structure of reovirus obtained by
cyro-electron microscopy. EMBO J. 10, 3129-3136.
Monastyrskaya, K., Booth, T., Nel, L., and Roy, P. (1994).
Mutation of two cysteine residues or deletion of the
amino or carboxyl terminus of nonstructural protein NS1
of bluetongue virus abrogates virus-specified tubule
formation in insect cells. J. Viral. 68, 2169-2178.
Murphy, F.A., Borden, E.C., Shope, R.E., and Harrison, A.
(1971). Physiochemical and morphological relationships
of some arthropod-borne viruses to bluetongue virus-a
new taxonomic group: electron microscopic studies. J.
Gen. Viral. 13, 273-278.
Neitz, W.O. (1948). Immunological studies on bluetongue 1n
sheep. Onderstepoort J. Vet. Sci. Anim. 23, 93-136.

36
Ohkuma, S., and Poole, B. (1978). Fluorescence probe
measurement of the intralysosomal pH in living cells and
the perturbation of pH by various agents. Proc. Natl.
Acad. Sci. USA 75, 3327-3331.
Oldfield, E., Hirasawa,
conservation of the
bluetongue virus, a
capsid protein VP2.

T., and Roy, P. (1991). Sequence
outer capsid protein: VP5, of
contrasting feature to the outer
J. Gen. Viral. 72, 449-451.

Osburn, B.I., Silverstein, A.M., Prendergast, R.A.,
Johnson, R.T., and Parshall, C.J. (1971). Experimental
viral-induced congenital encephalopathies. I. Pathology
of hydroencephaly and porencephaly caused by bluetongue
vaccine virus. Lab. Invest. 25, 197-205.
Pearson, J.E., Carbrey, E.A., and Gustafson, G.A. (1985).
Bluetongue and related orbivirus diagnosis in the United
States. In: Bluetongue and related orbiviruses. (T.L.
Barber, M.M. Jochim, and B.I. Osburn, eds.), pp. 469475. Alan R. Liss, New York.
Prasad, B. V.V., Wang, G.J., Clerx, J.M.P., and Chiu, W.
(1988). Three-dimensional structure of rotavirus. J.
Mol. Biol. 199, 269-275.
Purdy, M.A., Ghiasi, H., Rao, C.D., and Roy, P. (1985).
Complete sequence of bluetongue virus L2 RNA that codes
for the antigen recognized by neutralizing antibodies.
J. Viral. 55, 826-839.
Purdy, M.A., Ritter, G.D., and Roy, P.C. (1986). Nucleotide
sequence of eDNA clones encoding the outer capsid
protein, VP5, of bluetongue virus serotype 10. J. Gen.
Viral. 67, 957-962.
Roy, P. (1989). Bluetongue virus genetics and genome
structure. Virus Res. 13,179-206.
Roy, P . , Fu kush o , A . , Ri t t e r , D . G . , and Lyons , D . ( 1 9 8 8 ) .
Evidence for genetic relationship between RNA and DNA
viruses from the sequence homology of a putative
polymerase of bluetongue virus with that of vacclnla
virus: Conservation of RNA polymerase genes from diverse
species. Nucleic Acid Res. 16, 11759-11767.

37
Roy, P., Marshall, J.A.A., and French, T.J. (1990).
Structure of bluetongue virus genome and its encoded
proteins. Curr. Top. Microbial. Immunol. 162, 43-87.
Sanger, D.V., and Mertens, M.J. (1983). Comparison of type
1 bluetongue virus protein synthesis in vivo and in
vitro. In: Double-stranded RNA viruses (R.W. Compans and
D.H.L. Bishop, eds), pp. 183-191. Elsevier, New York.
Sohn, R., and Yuill, T.M. (1991). Bluetongue and epizootic
hemorrhagic disease in wild ruminants. Bulletin of the
Society of Vector Ecology 16, 17-24.
Spreull, J. (1905). Malarial catarrhal fever (bluetongue)
of sheep in South Africa. J. Comp. Pathol. Ther. 18,
321-337.
Tanaka, S., and Roy, P. (1994). Identification of domains
in bluetongue virus VP3 molecules essential for the
assembly of virus cores.
J. virol. 68, 2795-2802.
Theiler, A. (1908). Inoculation of sheep against bluetongue
and results in practice. Vet. J. 64, 600-607.
Thomas, C.P., Booth T.F., and Roy, P. (1990). Synthesis of
bluetongue virus encoded phosphoprotein and formation of
inclusion bodies by recombinant baculovirus in insect
cells; it binds the single-stranded RNA species. J. Gen.
Virol. 71, 2073-2083.
Urakawa, T., and Roy, P. (1988). Bluetongue virus tubules
made in insect cells by recombinant baculoviruses;
expression of the NS1 gene of bluetongue virus serotype
10. J. Virol. 62, 3917-3927.
Urakawa, T. Ritter, D.G., and Roy, P. (1989). Expression of
largest RNA segment and synthesis of VP1 protein of
bluetongue virus in insect cells by recombinant
baculovirus: Association of VP1 with RNA polymerase
activity. Nucleic Acids Res. 17, 3919-3927.
Van Dijk, A.A., and Huismans, H. (1980). The in vitro
activation and further characterization of the
bluetongue virus-associated transcriptase. Virology 104,
347-356.

38
Van Dijk, A.A., and Huismans, H. (1988). In vitro
transcription and translation of ·bluetongue virus mRNA.
J. Gen. Viral. 69, 573-581.
Venter, E.H., Viljoen, G.J., Nel, L.H., Huismans, H., and
Van Dijk, A.A. (1991). A comparison of different genomic
probes in the detection of virus-specified RNA in
orbivirus-infected cells. J. Viral. Methods 32, 171-180.
Verwoerd, D.W., Louw, H., and Oellermann, R.A. (1970).
Characterization of bluetongue virus ribonucleic acid.
J. Virol. 5, 1-7.
Verwoerd, D. W., Els, H.J., DeVilliers, E.M., and Huismans,
H. (1972). Structure of the bluetongue virus capsid. J.
Virol. 10, 783-794.
Verwoerd, D.W., Huismans, H., and Erasmus, B.J. (1979).
Orbiviruses. In: Comprehensive virology (H. FraenkelConrad and R.R. Wagner eds.), Vol. 14, pp. 285-345.
Plenum Press, New York.
Wade-Evans, A.M., Mertens , P.P . C., and Bostock, C.J.
(1990). Development of the polymerase chain reaction for
the detection of bluetongue virus in tissue samples. J.
Virol. Methods 30, 15-24.
Wang, L.-F., Doi, R.H., Osburn, B.I., and Chang, R.Y.
(1989). Complete sequence of the NS1 gene (S6 RNA) of US
bluetongue virus serotype 17. Nucleic Acids Res.
17,8002.
Wang, L.-F., Scanlon, D.B.; Kattenbelt, J.A., Mecham, J.O.,
and Eaton, B.~. (1994).
Fine mapping of a surfaceaccessible, immunodominant site on the bluetongue v1rus
major core protein VP7. Virology 204, 811-814.
Wang, L.-F., Hyatt, P.L., Andrew, M., Li, J.K.-K., and
Eaton, B.T. · (1996). Topography and immunogeneticity of
bluetongue virus VP7 epitopes. Arch. Viral. 144, 111123.
Wirth, W.W., and Dyce. A.L. (1985). The current taxonomic
status of the Culicoides vectors of bluetongue viruses.
In: Bluetongue and related orbiviruses (T.L. Barker and
M.M. Jochim, eds.), pp. 151-164. Alan R. Liss, New York.
Wu, X., Iwata, H., Chen, s.-Y., Compans, R.W., and Roy,
(1992). Multiple glycoproteins synthesized by the

P.

39
smallest RNA segment
66, 7104-7112.

(S10 of bluetongue virus)

J. Virol.

Yamaguchi, S., Fukusho, A., and Roy, P. (1988). Complete
sequence of neutralization protein VP2 of the recent US
isolate bluetongue virus serotype 2: Its relationship
with VP2 species of other US serotypes. Virus Res. 11,
49-58.
Yang, Y.-Y., Chiou, J.-F., Hwang, G.-Y., Huang, I.-J., and
Li, J.K.-K. (1992o). Evolutionary analyses of five US
bluetongue viruses using the cognate S2 genes. Virus
Res. 25, 241-249.
Yang, Y.-Y., Johnson, T.M., Mecham, J.O., Tam, J.P., and
Li, J.K.-K. (1992b). Epitopic mapping of linear and
conformation-dependent antigenic determinants on GP5 of
five US bluetongue viruses. Virology 188, 530-536.
Yang, Y.-Y., and Li, J. K.-K. (1992). Complete genomic
sequence of the GP5 protein gene of bluetongue Vlrus
serotype 11 and 17. Virus Res. 23, 164-171.
Yang, Y.-Y., and Li, J.K.-K. (1993). Glycosylation of the
major outer capsid protein of bluetongue viruses.
Virology 194, 350-354.
Yeager, M., Dryden, K.A., Olsen, N.H., Greenberg, H.B., and
Bakers, T.S. (1990). Three-dimensional structure of
rhesus rotavirus by cryoelectron microscopy and image
reconstruction. J. Struct. Biol. 110, 2133-2144.
Yu, Y., Fukusho, A., and Roy, P. (1987) Nucleotide sequence
of the VP4 core protein gene (M4 RNA) of US bluetongue
virus serotype 10. Nucleic Acids Res. 15, 7206.
Zhao, Y., Thomas, C., Bremer, C., and Roy, P. (1994).
Deletion and mutation analyses of bluetongue virus NS2
protein indicate that the amino but not the carboxy
terminus of the protein is critical for RNA-protein
interactions. J. Virol. 68, 2179-2185.

40
CHAPTER I I
CONSERVATION OF THE Ml (SEGMENT 4) GENE SEQUENCE
AND OF A LEUCINE ZIPPER MOTIF IN VP4 AMONG
FIVE US BLUETONGUE VIRUSES 1
ABSTRACT

Full-length eDNA coples of the M1 (segment 4) genes of
US bluetongue viruses serotype-2, -10, -11, -13, and -17 were
selectively amplified using genomic double-stranded RNA
segments from purified BTV

virion~

as templates and a

modified polymerase chain reaction (Clamp-R) .

They were

cloned into pUC19 plasmids and both strands of several clones
were sequenced.
nucleotides.

The length of all five M1 genes is 1981

The result ls contrary to the M1 gene of

serotype-10 sequenced by Yu et al.
nucleotides.

(1987), which has 2011

The 5'- and 3'-noncoding regions of M1 genes

are identical among all serotypes.

The plus sense strand of

the BTV M1 gene, which encodes the VP4 protein, possesses a
single, long open reading frame (ORF) with an initiation
codon (ATG) at nucleotides #9-11 and a stop codon (TAA) at
nucleotides #1941-1943.

This ORF encodes for a protein of

644 amino acid residues with a predicted molecular weight of
about 75 kDa and a pi of +7 to +7.9. A potential leucine
I

BTV-2 and BTV-11 M1 genes were cloned and sequenced by Dr. E. Hayama
and Ms. Y. Jeong, respectively.
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Zlpper motif was detected near the carboxyl terminus of the
deduced VP4 amino acid sequence.

The phylogeny established

using the sequences of these five cognate M1 genes is
consistent with the results of our prevlous phylogenetic
studies of cognate genome segments 5, 6, 8, 9, and 10.
Serotype-10, -11, -13, and -17 are closely related and
serotype-2 is the most distantly related among the five US
BTV serotypes.
INTRODUCTION

Bluetongue Vlrus

(BTV), classified in the Orbivirus

genus of the family Reoviridae (Borden et al., 1971; Murphy
et al.,

1971), is an arthropod-borne virus that causes the

bluetongue disease in domestic and wild ruminants.

This

disease was first discovered in South Africa more than a
century ago and then found in various other parts of the
world after 1949.

BTV is an icosahedral-shaped particle

consisting of a double-layered protein coat.

Its genome lS

composed of 10 segmented double-stranded RNAs

(dsRNAs)

(Verwoerd et al., 1972).

Each segment of the viral genome

except the S4 gene encodes a single protein (Grubman et

al., 1983; Sanger and Mertens et al., 1983; Roy, 1989).
The double-layer viral protein coat contains two outer
capsid proteins

(VP2 and VP5) and five inner capsid
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p r o te ins

(VPl, VP3, VP4, VP6, and VP7). Four nonstructural

p r ot eins

(NSl, NS2, NS3, and NS3A) have also been detected

i n BTV-infected cel l s

(Hyatt et al., 1991) and by in vitro

t ranslation (Grubman et al., 1983; Mertens et al., 1984;
Van Dijk and Huismans, 1988).
VP4, a minor coffiponent of the inner capsid of BTV, 1s
encoded by the M1

(segment 4) gene.

the structure and function of VP4.

Little is known about
To gain a better

understanding and to investigate the potential biological
function(s)

of this protein as well as the evolutionary

relationship of the five US bluetongue v1ruses, the M1
genes of BTV serotype-2, -10, -11, -13, and -17 were cloned
and sequenced.
MATERIALS AND METHODS

Virus preparation
The seed stocks of the five US BTV serotypes were
provided by Arthropod-Borne Animal Disease Research
Laboratory of USDA.

They were three times plaque-purified

in L-929 as described by Kowalik and Li (1987).

The

viruses were propagated in baby hamster kidney (BHK-21)
cells grown in roller bottles (Corning) at a multiplicity
of infection (M.O.I.) of 1.

Viral particles were purified

by using sucrose gradients as described by Kowalik and Li
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(1989)

and Kowalik et al.

scraped

fro~

(1990).

BTV-infected cells were

roller bottles 2 days postinfection and

pelleted at 3000x g for 25 mln.

The pellets were then

resuspended in NTE (200 mM Tris-HCl, pH 8, 100 mM NaCl, 2
mM EDTA)

buffer containing 1%

(w/v) deoxycholate.

(w/v) Triton .X-100 and 0.5%

After 10 min of incubation at room

temperature, insoluble particles were removed by
centrifuging at 2000x g for 5 min at room temperature.

The

virus containing supernatant was then loaded onto a 40%
(w/v)/60%
Tris-HCl

(w/v) sucrose step gradient containing 200 mM
(pH 8) and centrifuged for 90 min at 37,500 rpm ln

a Beckman SW41Ti rotor.

At the end of centrifugation, the

partially purified viruses located at the interface of the
two sucrose solutions were collected and resuspended in 200
mM Tris-HCl

(pH 8) containing 1%

and 10 mM dithiothreitol

(DTT).

(w/v) N-lauroyl sarcosine
The virus suspenslon was

incubated at 37 ° C for 30 min and pelleted through a 1-cm
40 % (w/v) sucrose cushion as described above.

The purified

vlruses were then resuspended in 200 mM Tris-HCl
kept at -20° C.

(pH 8) and

Each individual serotype was confirmed by

neutralization assays and by comparing the characteristics
electrophorograms of the viral proteins and dsRNAs on 10%
SDS-PAGE (Li et al., 1989).
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Preparation of

genom~c

dsRNA

The total dsRNA was extracted from the viral particles
by the SDS-KCl method according to Li et al.
Kowalik et al.

(1990).

(1989)

and

SDS was added to the purified virus

solution to a final concentration of 1% SDS.

The mixture

was then boiled for 1 mln and chilled on ice for 5 min.

An

equal volume of 0.5 M KCl was added to the mixture, and the
mixture was kept on ice for another 5 min.

The viral

proteins and genomic dsRNA were separated by centrifuging
at 10,000x g for 10 min (4 ° C) in a microcentrifuge.

The

dsRNA in the supernatant was then purified by
phenol/chloroform extraction and ethanol precipitation at
-20° C for 1 hr.

The dsRNA was pelleted by centrifuging at

10,000x g for 10 mln.

The pellet was washed with 70%

ethanol and dried under vacuum.

The dsRNA pellet was then

dissolved in double distilled water (ddH 2 0) and kept at -20 °
C until use.

Amplification of the
cognate Ml cDNAs
The full-length cDNAs of M1 genes were amplified uslng
the purified BTV dsRNA as templates by the Clamp-R method
(Kowalik et al., 1990).

A pair of primers, containing

sequences complementary to the termini of BTV-11 M1 gene
(Kiuchi et al., 1983) and anchored with a Psti restriction
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enzyme site (5'-AGTCGACCTGCAGGTTAAAACATGCCTGAG-3' a n d 5'AGTCGACCTGCAGGTAAGTTGTACATGCCC-3'), was used to
specifically amplify the full-length eDNA of the Ml genes
from each BTV-2, -10, -11, -13, and -17.

A solution (20 pl

total) containing 0.3 pg of dsRNA templates and 0.5 pg of
primers was boiled for 4 min and then chilled on lee
immediately.

The template-primer mixture was then mixed

with 1 pl of 10 rnM dNTP, 5 pl of lOx buffer (100 rnM TrisHCl, pH 8.3, 0.5 M KCl, 15 mM MgC1 2 ,
gelatin),

and 0.1%

(w/v)

0.5 pl (12.5 units) of avian myeloblastosis

virus-reverse transcriptase (AMV-RT)

(Promega), and 0.5 pl

(2.5 units) of native Taq DNA polymerase.

The mixture was

then overlaid with 100 pl of mineral oil to prevent
evaporation.

The amplification was carried out in a

programmable thermal cycle reactor (Ericomp Corp.).

First-

strand eDNA was synthesized at 42 ° C by AMV-RT for 1 hr and
subsequently amplified by 35 cycles of amplification, which
included denaturation (95° C for 2 min), annealing (37 ° C for
2 min), and extension (72 ° C for 10 min).

A final extension

was done at 72 ° C for 20 min.
Cloning of Ml cDNAs
The amplified full-length cDNAs of Ml genes were
restricted with Psti endonuclease and electrophoresed
through a 1% low melting point agarose gel with O.Sx TBE
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buffer (lx TBE is 90 mM Tris-borate, pH 8, 2 rnM EDTA).

The

band containing the full-length Ml eDNA was excised from
the gel and melted at 55° C for 5 min.

Fifteen pl of the

gel solution containing M1 eDNA was ligated with Pstidigested pUC19 vector in a final 50 pl of ligation mixture
[containing 5 units of T4 DNA ligase, 1x ligation buffer
(50 mM Tris-HCl, pH 7.8, 10 mM MgC1 2 ,
2.5 pg/ml BSA)]

10 mM DTT, 1 mM ATP,

(NEB) at room temperature for 2 hr.

Ten pl

of the ligation mixture was mixed with 100 pl of 50 mM CaCl z
and 30 mM MgCl z and then used to transform 100 pl of
competent E. coil strain XL-1 blue.

The mixture was

incubated on ice for 40 min, heat shocked at 42 ° C for 2
min, and grown ln 0.8 ml of LB (10 g tryptone, 5 g yeast
extract, 5 g NaCl per litter) at 37 ° C for 1 hr.

The E.

coli culture was then plated on LB plates containing 1%
agar, 50 pg/ml ampicillin, 0.1 mM isopropyl-1-thio-Dgalactoside (IPTG), and 20 pg/ml 5-bromo-4-chloro-3indolyl-D-galactoside (X-gal).

After 16 hr incubation at

37 ° C, white colonies were picked and grown in LB containing
ampicillin for plasmid isolation.

About 1.5 ml of

overnight E. coli culture was pelleted by centrifuged at
10,000x g for 20 sec at room temperature.

The cells were

resuspended in 100 pl of lysis buffer (25 mM Tris-HCl, pH
8, 10 mM EDTA, 50 mM glucose) and incubated at room
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t~mpe rat u re

for 5 m1n. The suspens1on was then mixed with

200 pl of freshly prepared alkaline solution (0.2 N NaOH,
1 % SDS)

and incubated on ice for 5 m1n.

The mixture was

t hen mixed with 150 pl of ice-cold potassium acetate (pH
4.8) and incubated on 1ce f8r 5 min.

The plasmids were

separated from the cellular debris by centrifuging at
10,000x g for 5 min at 4° C.

RNAse A was added to the

supernatant to a final concentration of 20 pg/ml to digest
cellular RNA for 30 min at 37 ° C.

An equal volume of

phenol/chloroform was added to the mixture, vortexed, and
centrifuged at 10,000x g for 2 m1n.

The plasmids in the

supernatant was mixed with 2.5x volume of cold 100% ethanol
(-20 ° C)

and incubated at -80° C for 1 hr.

The plasmids were

pelleted by centrifuging at 10,000x g for 10 min at 4° C and
washed with 70% ethanol.

The DNA pellet was dried under

vacuum and dissolved in TE.

The presence of the M1 gene

insert in the plasmids was checked by digesting with Fsti
restriction enzyme and analyzed by 1 % agarose gel
electrophoresis.
DNA sequencing

Plasmids were purified from 50 ml of overnight E.

coli

culture as described above except that they were further
purified with polyethylene glycol

(PEG).

Plasmids were

then dissolved in 168 pl of ddH 2 0 and mixed with 32 pl of 5
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M NaCl and then 200 pl of 13% PEG.

The mixture was kept on

lee for a minimum of 30 min and centrifuged at 10,000x g
for 10 min at 4° C.

The DNA pellet was then washed with 70 %

ethanol, dried under vacuum,

then dissolved in TE and kept

at -20 ° C until use.
One pg of plasmid DNA in 40 pl of water was mixed with
4 pl of denaturation solution (2 N NaOH,
kept at room temperature for 5 min.

2 mM EDTA)

and

After the incubation,

16 pl of ddH20 and 6 pl of 3M sodium acetate

(pH 4.6) were

added to the denatured DNA solution sequentially.
precipitate the DNA, 150 pl of cold 100% ethanol

To
(-20 ° C)

was added to the mixture, mixed, and kept at -80° C for 20
mln.

The denatured DNA was pelleted by centrifuging at

10,000x g for 5 mln.
ethanol

(-20 ° C)

The pellet was rinsed with 70%

and vacuum dried.

DNA was then dissolved

in 7 pl of ddH 20 and kept on ice until use.
annealing reaction,
of reaction buffer

To start the

1 pl of primer (0.5 pmole/pl)
(200 mM Tris-HCl, pH 7.5,

and 5 pl

100 mM MgC1 2 )

were added to the 7 pl DNA solution.

The primer-template

mixture was kept at 37 ° C for 30 min.

For the labeling

reaction,

1 pl of 0.1 M DTT, 2 pl of diluted

(1.25 pM dGTP,

label~ng

1.25 pM dCTP, and 1.25 pM dTTP)

pl of [a- 35 S]-dATP (10 pCi/pl)
diluted sequenase

(Amersham),

(USB),

mlx
0.5

and 2 pl of

(USB) were added to the primer-template
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mixture; the reaction was carried out at room temperature
for 5 min.

The termination procedure was started by

transferring 3.5 pl of the previous solution to each of the
four termination m1xes (ddATP, ddCTP, ddGTP, ddTTP), which
were pre-warmed at 37 ° C and incubated at 37° C for 5 min.
The reaction was stopped by adding 4 pl of stop solution
(95% formamide, 20 mM EDTA, 0.05% bromophenol blue,
xylene cyanol-FF) .

0.05%

The DNA mixtures were denatured at 80° C

for 2 min and chilled on ice immediately before loading
into a 5% polyacrylamide sequencing gel (acrylamide : bisacrylamide, 30:1) containing 7 M urea.

Five pl from each

of the mixtures were loaded into a single lane.
Electrophoresis proceeded at 2000 volts with 1x TBE buffer
until the desired separation was reached.

The temperature

of the sequencing gel was kept at 55 ° C during the entire
run.

The sequencing gel was soaked in fixing solution (5%

acetic acid, 15% methanol)
remove urea.

for 15 min to fix the DNA and

The gel was then dried using a slab gel drier

(Bio-Rad, Model 483)

for 2 hr at 80° C.

The dried gel was

exposed with Kodak XAR-5 film at room temperature for
autoradiography.

Both strands of the inserted genes of

different clones from different preparations were
sequenced.
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Phylogenetic analysis

Molecular phylogeny was analyzed by the PILEUP program
l n the GCG software (Devereux et al., 1984) using both the
nucleotide and deduced amino acid sequences of the entire
M1 genes.
RESULTS

The full-length cDNAs of 5 BTV M1 genes were amplified
(Fig. 1) using the purified BTV dsRNA as templates by the
Clamp-R method.

The amplified e DNA has a similar size as

that of M1 gene dsRNA segment (about 2000 bp) .

The eDNA

was digested with Psti restriction enzyme and cloned into
pUC19 plasmid for sequenclng.
All of the cloned eDNA of M1 genes were full-length
except BTV-2, which has one Psti restriction enzyme site at
position #1786-1790.

The M1 gene of BTV-2 was cloned as

two fragments in pUC19 at Psti site.
The M1 gene of each US BTV is 1981 nucleotides.

They

are highly conserved and can be aligned without any gaps
(Fig. 2).

A single long, ORF was found ln the M1 gene of

BTV-2, -10, -11, -13, and -17 with a start codon (ATG) at
nucleotides #9-11 and a stop codon (TAA) at nucleotides
#1941-1943.

This ORF has a coding capacity of 644 amino

acids and is flanked with an 8-nucleotide noncoding region
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at its 5'-end and a 38-nucleotide noncoding reglon at its
3'-end, respectively.

Both ends of the noncoding regions

perfectly matched among all five US BTV serotypes.

The

coding sequences of Ml genes of BTV-2, -10, -11, -13, and 17 could also be aligned without any gaps.
(1987)

Yu et al.

reported that the sequence of BTV-10 Ml gene

contained 2011 nucleotides instead of the 1981 nucleotides
determined in this study.

The difference is the presence

of a direct repeat of 30 nucleotides at #1610-1639.

This

repeat was not found in the BTV-10 Ml gene examined in this
study.
The deduced amlno acid sequences of VP4 are aligned
and shown in Fig. 3.

There is a high degree of sequence

identity (96-99%). Hydropathy analysis indicates conserved
hydrophobic amino and hydrophilic carboxyl termini.

The

VP4 proteins have an estimated molecular weight of 75-76
kDa and a pi between 7 to 7.9 (Table 1).

The predicted VP4

.

of BTV-2, -10, -11, -13, and -17 has 644 amino acid
residues, 10 fewer than that of BTV-10 reported by Yu et

al.

(1987).

The 10 extra amino acids of BTV-10 VP4 are

resulted from the 30 extra nucleotides in the sequence. The
deduced protein contains about 32% charged amino acid
residues and very little cysteine and glutamine (Table 1).
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Phylogenetic analysis of the five US BTV serotypes was
performed using both nucleotide and deduced amino acid
sequences as shown in Fig. 4.
~n

Table 2.

The results are summarized

The nucleotide sequences of the M1 gene of the

five US BTVs are highly conserved.

The M1 genes of BTV-11

and -17 has the highest identity of 99.44%
1981 nucleotides mismatches).

(only 10 out of

The M1 gene of BTV-2

lS

the

most distantly related among the five US BTVs (Table 2 and
Fig. 4).
DISCUSSION

The full-length cDNAs of the M1 genes were amplified
by PCR from all five US BTV serotypes-2, -10, -11, -13, and
-17

(Fig. 1).

The M1 genes of all five US BTVs are highly

conserved containing 1981 nucleotides and could be aligned
without any gaps

(Fig. 2).

The M1 genes of BTV-11 and -17 had the highest
identity of 99.44%

(10 mismatches out of 1981 nucleotides).

The M1 gene of BTV-2 is more distantly related to the other
four US BTV serotypes than the four are among themselves
(Table 2 and Fig. 4).
Even though the nucleotide identity among these five
US BTV serotypes ranged between 89-99%, the amino acid
sequence mismatches were less than 4%.

The reason for this
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difference is that most of the nucleotide mismatches are
found in the third base codon position (Table 3).

The M1

gene of BTV-2 has 68-71 % relatedness to the other four
serotypes in the third base codon position calculated by
the method described by Wiener and Joklik (1987).

The M1

genes among the BTV-10, -11, -13, and -17 are very closely
related (>97 % identity) and they have more than 93%
identity even at the third base codon position of codons
(Table 4).

An interpertation of these analyses is that

BTV-2 diverged from the ancestor of the other four US BTV.
This result is consistent with the conclusion derived from
our previous studies of segments 1; 3 5, 6, 8, 9, and 10
(Hwang et al., 1992a; 1992b; Yang et al., 1992; Yang and
Li, 1992; Hwang et al., 1993; 1994; Huang et al., 1995).
In this study, we reported the M1 genes contain 1981
nucleotides instead of 2011 reported in BTV-10 by Yu et al.
(1987).

We concluded that the difference is due to a

direct repeat of 30 nucleotides at #1610-1639.

The repeat

also caused the increase of 10 amlno acid residues of BTV10 VP4 that they had reported.

This was not found ln the

BTV-10 sequence of this study.
Analysis of the deduced amino acid sequences of VP4
revealed several interesting predicted structures and
functions.

Potential amidation and glycosylation sites
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were found at position #106-109 (IGRR) and #459-462
of all five serotypes, respectively.

(NGSY)

Six potential N-

myristylation sites were also found in VP4 at position
#297-302

(GGAFSS),

#548-553

(GLDLSG), #562-567

(GMREGA) .

#298-303 (GAFSSA),

#419-424

(GLEPSI),

(GAYVTD), and #627-632

Potential cAMP- and cGMP-dependent protein

kinase phosphorylation sites could also be located at
position #208-211

(KKRS) of all five BTV serotypes.

Many

more potential phosphorylation sites for casein kinase II
phosphorylation, protein kinase C phosphorylation, and
tyrosine kinase phosphorylation are found in VP4.

However,

NS2 is the only reported phosphorylated BTV viral protein
(Devaney et al., 1988; Huismans et al., 1987).
Two regions at residues #296-299 (DRLG) and #550-553
(DLSG) of all five US BTV VP4 proteins have the DX 2G
sequence motif, which is conserved in all GTPase (Bourne et

al., 1991).

In the study of p21 ras , products of the ras

oncogenes and proto-oncogenes, the asparate binds the
catalytic Mg 2+ through an intervening water molecule,
whereas the amide proton of the glycine forms a hydrogen
bond with the r-phosphate of GTP.

These regions may be

involved in the GTP-binding activity of VP4.
A potential leucine-zipper motif located at positions
#523-555 (LRVESSVLRVRNPTLHETADELRVRNPTLHETADELQRMGLDL)
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contains a repeat of leucine residues at every seve n th
position (Fig. 5) and a short stretch of adjacent charged
amlno acid residues.

This is the first leucine-zipper

motif reported in dsRNA viruses.
to form an amphipathic a-helix.
prollne residues

This motif is predicted
An unusual cluster of

(5 out of 9) was also located about 10

amino acids before this unique motif.

A similar proline-

rich region was identified as a Src homology 3 (SH3)
binding site of the SH3 binding protein (Ren et al., 1993).
The proline-rich region of VP4 may serve a similar function
as a protein-protein association module to facilitate
binding to other viral proteins.
The potential leucine-zipper motif of VP4 resembles
that of many known transcriptional transactivators
(Landschulz et al., 1988), which have a heptad repeat of
five leucine residues and a basic region adjacent to the
leucine repeats.

Like jun, this region has uncharged

residues at the fifth position of the repeat.

It also has

uncharged residues at every first and fifth positions,
which have been reported to stabilize the zipper ln a
coiled-coil helical conformation (O'Shea et al.,
et al., 1990).

1989; Hu

The first and the fifth positions of this

heptad are usually occupied by hydrophobic amino acids (the
4-3 rule)

(Zhou et al., 1992).

Thus one side of the helix
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lS predominantly hydrophobic.

Another model of a coiled-

coil has symmetrical secondary hydrogen-bonding between the
polar side chain of one helix and the peptide backbone of
the opposite chain (Tropsha et al., 1991).

Although helix-

breaking proline and glycine residues are found in this
region of the VP4 leucine-zipper motif, a single glycine
inserted by mutation did not abolish the function of yeast
GCN4 protein, which is a DNA-binding protein with a
leucine-zipper motif (Pu and Struhl, 1991).

The T.

thermophila isoleucyl-tRNA synthetase (ileRSs) has two

leucine-zipper motifs in the carboxyl one third of the
protein (Csank and Martindale, 1992) that are conserved ln
the other ileRSs.
motifs.

Proline residues are also found in these

In a recent report by Xia and Lai

(1992),

the

hepatitis delta antigen (HDAg) with a leucine-zipper-like
motif containing a proline residue is involved in the
replication of HDV RNA.

The results of this study

demonstrated that the leucine-zipper motif is responsible
for HDAg dimerization and the motif on the HDAg is
indispensable for its activity in HDV RNA replication.
Although the potential leucine-zipper motif found ln
the BTV VP4 does not match all of the criteria of a DNAbinding protein with a leucine zlpper motif (bZIP), VP4
shares several features with proteins involved in RNA-
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~rotein

i nteraction (Pu and Struhl, 1991; Xia and Lai,

19 92).

These RNA-bind i ng proteins have the potential to

fo rm an amphipathic a -helix, in which a proline residue(s)
i s found inside the heptad, and a basic region is located
downstream of the motif.
Recently, VP4 e x pressed 1n insect cells in a
baculovirus expression system has been suggested as the
guanylyltransferase involved with capping BTV mRNAs
Blois et al., 1992).

(Le

However, this has not been definitely

proven . The character i stics of VP4 suggest that VP4 might
play an important role in BTV genome transcription and
replication.

The biological function(s) of VP4 is still

unknown but the investigation of its potential function(s)
is currently in progress.
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TABLE 1
Amino Acid Content of Deduced VP4 of the Five
US Bluetongue Viruses

Ala (A)
Cys ( C)

BTV-2
38
4

BTV-10

BTV- 11

BTV-13

BTV-17

38
5

39
5

39
5

38
5

Asp (D)
Glu (E)

46

49

48

48

48

45

45

46

46

45

Phe (F)

24

25

25

24

25

Gly (G)

34

34

33

33

33

(H)

26

25

25

24

25

Ile (I)

40

37

37

38

39

Lys

( K)

38

36

37

36

37

Leu

( L)

62

62

62

62

60

Met (M)

27

27

28

26

27

Asn (N)

22

23

24

25

24

Pro

29

30

30

30

31

Gln {Q)

9

8

8

9

8

Arg ( R)

53

57

55

53

56

Ser

( s)

41

36

36

37

38

Thr (T)
Val (V)

20

23

22

22

22

44

41

41

42

40

Trp

(W)

15

15

15

15

15

Tyr ( Y)

27

28

28

30

28

A+G

72

72

72

72

71

S+T

61

59

58

59

60

D+E

91

94

94

94

93

D+E+N+Q

122

125

126

128

125

H+K+R

117

118

117

113

118

D+E+H+K+R

208

212

211

207

211

I+L+M+V

173

167

168

168

166

F+W+Y

66

68

68

69

68

pi

7.82

7.58

7.43

7.06

7.76

(kDa)

75.1

75.4

75.4

75.3

75.4

His

MW

(P)
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TABLE 2
Sequ e nce Identity Matrix of the M1

(Segment 4) Genes

among the Five US Bluetongue Viruses

Identity of sequences
BTV-2
BTV-2

( %)

BTV-10

BTV-11

BTV-13

BTV-17

89.30

89.55

89.10

89.30

98 ·. 69

98.44

98.49

98.38

99.44

BTV-10

97.36

BTV-11

97.52

99.69

BTV-13

96.74

98.91

99.07

BTV-17

97.52

99.69

99.84

98.13
99.07

Note. Numbers above the diagonal indicate the percentage of
identity of nucleotide sequences and numbers below the
diagonal indicate the percentage of identity of amino acid
sequences.
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TABLE 3
Number of Mismatches Between BTV Ml

(Segment 4) Nucleotide

Sequences Based on Codon Position

Codon

BTV-17

BTV13

positions

mismatches %

mismatches %· mismatches %

BTV-10
1st
2nd
3rd
BTV-17
1st
2nd
3rd
BTV-13
1st
2nd
3rd
BTV-11
1st
2nd
3rd

4
2
26

<1
<1
4

BTV-11

BTV-2
mismatches %

6
4
22

<1
<1
4

4
2
21

<1
<1
4

32
19
161

5
3
25

4
2
32

<1
<1
5

2
0
8

<1
0
2

32
16
165

5
2
23

4
2
26

<1
<1
4

34
18
164

5
2
23

31
18
156

5
2
22
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TABLE 4
Comparison of the Nucleotide ·Sequence Divergence Pattern of
BTV M1

(Segment 4 ) Genes Based on Codon Positions

Serotype
2 vs. 10

2 vs. 17

2 vs. 13

2 vs. 11

Among BTV-10,
-11' -13, and

Base
codon
position

Number of
matched
nucleotides

Number of true
rnatchesa /% of
true rnatchesb

Extent of
relatednessc

1
2
3

613/644
629
494

452/70
468/72
333/51

94
97
69

1
2
3

613/644
632
495

452/70
471/73
334/52

94
98
69

1
2
3

611/644
630
494

450/70
469/73
333/52

93
97
69

1
2
3

614/644
630
504

453/70
469/73
343/53

94
97
71

1
2
3

>98
>98
>93

-17

a. Number of matches mlnus the number of expected matches
among random sequences which is 161 in M1 genes

(25% of

6 4 4) •

b. Ratio of the number of true matches to the total number
of nucleotides

(percentage). A value of 75% and 0%

represents complete identity and divergence, respectively.
c. Ratio of number of true matches divided by (644-161)
(percentage) .

66

367Sbp
2323bp
1929bp

~M1

1371bp
1264bp

702bp

FIG. 1. Amplificatio n a n d synthesis of full-length eDNA of
M1

(segment 4) gen es of fiv e US BTV serotypes.

Total

genomic BTV dsRNA was mixed wi t h pr i mers (see text)
complementary to th e 3 ' -ends of M1 gene.

The dsRNA was

reverse transcribed into eDNA and then amplified by PCR.
Ten percent of the f inal product was analyzed by 1% agarose
gel electrophoresis.

Lan e 1: 0.5 pg of BstE II digested

lambda DNA marker; Lan e 2: BTV-2; Lane 3: BTV-10; Lane 4:
BTV-11; Lane 5: BTV-13; Lane 6: BTV-17; Lane 7: 0.3 pg BTV13 genomic dsRNA.
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FIG. 2. Nucleotide sequence alignment of the M1
genes of five US bluetongue Vlruses.

(segment 4)

The initiation (ATG)

and termination codons (TAA) are indicated by boxes.

A

total of 1981 nucleotides were found ln the M1 genes of
BTV-2, -10, -11, -13, and -17.

Asterisks represent

nucleotides identical to those of BTV-10.

Thymine

(T)

shown ln place of uracil presented ln the genomlc RNA.
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BTV l O ACCAGCACCOTTTAC~CCOTCTTATGCCACGTATATGACCCAATAGCACCTGAGTGTTCAGATCCAAACGTTATACTTC 720
BTV17 ••••••••••••••••••A•••••••••••••••••••••••••••••c•••••••••••••••••o••••••••••·••
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• * • • •• • • • • •••• • • • • • • •A.• • • • • • • • • • • • • • *C*T* • • • • • • • • • •c• •A•c• • • • • • • • • * • • • •• • * • • • * • •

2

B ~ VIO

AT AATATTATGCTGCATTCAAAGAAAGACATTTTCAAACATATGAAIIIIIIGAAACGTCTTGAGACACTTTTCATATGC 800

BT '/1 7

••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••

BT \.' 1)

• • • • •••••• •••• • ••••• • • • •• •• •• • • • •• ••••T••••••• • •• • •• • • • •• • • • '• • •• • • • •• • ••• •• ••••
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••••••••••••••••••••••••••A•••••••••••••••••••••••••••••••••••••••••••••••••••••

a TV 2

• • • • •c• • • • • • • • • • • • ,.. • • • • • • • • • • • • • • • • • • • • • • • • • • •c• • • • •A• • • • • • • .. • • ·A•

·c• •c•

••••••••

8 TV 10 GA TCTATCOTCAOATCGATCCCAGATGAA TGATCA '~' GAGTCCCAGACGACCAGCTTTGCGCAGCATACA TTGGQTCAGCA 8 8 0
•••••••••••••••••••••••••••••••••••••••••••••••A.••••••••••••••••••••••••••••••••
8TV 1) • • • * * • • • • •• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •A.• •A,• • • • • • • • • • • • • • • • * • • • • • • • • • • • • • • •
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8TV17

B7V

2 ••••
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eTV 2

•c••A.• •• • • • • •• • • • • • • • • •c· • • • ·a• • • •A• • • • ·AT• • • • • • •A• ·c· •A• • • • •• • •o• • •• •• • · • ••
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!TV 2 • • • • •• •• ••T•••c•Tc••• ••• •c;••••••••T••••• • ••• •• • • •c• • • •• ••• •••• •••••• •••• •••A••••
8TV10 TACTCACACOTGGATCGCCACATGCATCCAGACGCTTCCGTGACGAAAGTTGTTTCACGTGATOTGCCCAAAATCGTCGA lllO
a1Vl7 •••••••••••••••••••••••••··········•••••••••••••••••••••o•••••••••••••••••••••••
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BTV 2 • • ••• ***T**A••••••••T•••••c•••••T••A•••••A•T••••••••••••o••••••••A••••••••••••••
8TVl0 ATTGTATCACOCTCGCOATCOTGGTAGATTTCTAAAAAAGAGACTATTTGAACACCTTCATATTCTACOTAAGAATCOAT 1200
erv11 ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••o•••••A•••••••
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•c• · • • · •o•o• •o• •c• ·o• • • • • • • • • • • • • • · · · • • •c• •• • • • • • • • • • • •• •

8TV10 TGTTACACOAAAOTGATOAGCCACGAGCGTATCTGTTTTATTTGACCAATCGCTGCAATATCGCATTGCAGCCTAGTArT 1280
arv11 · · · • · •• • • • • • • • • • • • • • • • • • • • • • •c• • • • • • • • • • • • • • • • • • • • • • • • • • • •c•• • •• • •• • • • • • • • • • •• • •

arv 1 J
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BTV 2
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8TV10
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!TV l 7
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BTV 2 • • • **A* •• • •• • • • * • •• • • • • • • •c• • • • •A• •c• • • • •A• • • • • • • •T• • •c• • • • •• • • • • • • • • • • • • •• • • •• •

BTVlO ACCCACATCTACCCTTATCCTCAACCCATCCTACCGCGATATCAGAATTCTAGATCCCAATGCCCCAATCCTATTCCTAA 1440
BTV17 •••••••••••••••••••••••••••••••••••••••c••••••••••••••••••••••••••••••••••••••••
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BTV 2 • • • • * • • • • * • *T* •c• ** * • * • •T• • • • •T• • • *AT• • • • • • • • • • • • • • • • • • • •r• • • * • * •••• * • • * •• *T* • • •
BTVlO TGTCCACGTACCCCGATATCCTAAACAAAGATTTGACGTATCACCCTGCGTCGCCCATGAATTTTOCTGTTTCGCTAAAO 1520
8TVl7
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FIG. 2-Continued
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FIG. 3 . Alignment of the deduced amlno acid sequences of
the VP4 proteins of the five US bluetongue viruses.

The

asterisks represent arnlno acids identical to those of BTV10. A total of 644 arnlno acids were found ln the VP4 of

BTV-2, -10' -11' -13' and -17.

The seventh leucines of the

potential leucine-zipper motif (#523-551)
arrows.

are indicated by
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Nucleotide

Amino Acid

. . - - - - - - - - - - - - BTV 2

BTV 2

BTV 13

BTV 13

BTV 10 .

BTV 10

BTV 11

BTV 11

BTV 17

BTV 17

FIG. 4. Results of phylogenetic analysis of the five US BTV
serotypes based on nucleotide and deduced amlno acid
sequences of Ml

(segment 4) genes.
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FIG. 5. Helical wheel representation of the leucine repeat
found in the pdtential leucine-zipper motif in the VP4
proteins of five US bluetongue viruses.
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CHAPTER I I I
DELINEATION OF THE ANTIGENIC DETERMINANTS AND
SSRNA-BINDING DOMAINS OF THE MULTIMERIC
BLUETONGUE VIRUS VP4 PROTEIN

ABSTRACT

Heterologously expressed bluetongue Vlrus

(BTV)

core protein VP4 was purified to near homogeneity.

lnner
Six

oligoclonal antibodies produced in rabbits were able to
react with VP4 protein.

These six linear epitopes of VP4

were mapped to both termini and the middle of the protein.
Enzyme-linked immunosorbent assay (ELISA) and peptide
competition assay demonstrated that these slx linear
epitopes are surface accessible.

VP4 was shown to be a

ssRNA-binding protein, and the leucine-zipper motif of VP4
was not required for the RNA-binding activity.

VP4 protein

exhibited similar binding activity to both capped and noncapped mRNAs.

Its RNA-binding activity was not specific to

BTV ssRNA since VP4 protein could bind to poly(U), and its
BTV ssRNA-binding activity could be competed out in the
presence of yeast tRNA in a reaction mixture. VP4 was also
shown to be an oligomer by chemical cross-linking VP4 that
was produced by in vitro translation.

One RNA-binding

domain was mapped by Northwestern assay and deletion mutant
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analyses between amlno acid residues #112-158.
sequence

sp~cific

Using

synthetic peptides corresponding to the

arglnlne- and lysine-rich regions of VP4, four other
potential ssRNA-binding domains of VP4 were identified.
Altho u gh BTV mRNA was assumed to be capped,

I found that

both capped and non-capped BTV mRNAs synthesized in vitro
were translated with similar efficiency by a wheat germ
extract in vitro translation system.
INTRODUCTION

Bluetongue Vlrus (BTV), an agent that causes
bluetongue disease ln domestic animals and wild ruminants,
has been known for more than a century.

It is classified

in the Orbivirus genus of the family Reoviridae (Borden et
al., 1971; Murphy et al., 1971).

The icosahedral-shaped

BTV has a double layered protein coat, and its genome is
composed of 10 segmented dsRNAs

(Verwoerd et al., 1972).

There are two outer capsid proteins

(VP2 and VP5)

and five

lnner capsid proteins (VP1, VP3, VP4, VP6, and VP7)
double-l ~ yer

in the

viral protein coat.

The three minor inner core proteins (VP1, VP4, and
VP6) were suggested to be the viral RNA-dependent RNA
polymerase and the capping enzymes of BTV (Van Dijk and
Huismans, 1980; Urakawa and Roy, 1989; Le Blois et al.,
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1992).

Recombinant VP1 expressed ln insect cells had RNA-

dependent RNA polymerase activity ln the presence of
poly(U)

templates

(Urakawa and Roy, 1989).

VP6 has been

shown to have nucleic acid binding activities, and its
nucleic acid binding domains were identified by Hayama and
Li

(1994).

However, the biological function(s)

still unknown.

of VP6 lS

VP4 prepared from both purified virus and

recombinant proteins has a GTP-binding activity (Le Blois
et al., 1992).

It is the prime capdidate for being the

guanylyltransferase of BTV.

However, the capping activity

of VP4 has never been proven.
The M1 genes coding for the VP4 proteins of five US
BTV serotypes were cloned and sequenced (Chapter II).

The

sequences of all five VP4 proeins have a very high degree
of homology (96-99%) and conserved hydrophilic and
hydrophobic regions, determined from hydropathy plot
analyses.

From the deduced amino acid sequences of VP4, a

unique leucine-zipper motif and several basic amino acid
clusters were found in this protein.

These motifs are

found in many nucleic acid binding proteins (Perutz, 1992).
Whether VP4 is a nucleic acid binding protein is unknown.
In this study,

I intend to characterize the structure

of VP4 as well as to investigate the function(s)

of VP4.
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Using recombinant VP4 proteins, VP4 was shown as an RNAbinding protein and its structure was characterized.
MATERIALS AND METHODS

Construction of recombinant
plasmids

The full-length BTV-13 M1 gene in the plasmid
pUC19BTV13M1

(Chapter II) was subcloned into the Pst I site

of a baculovirus expression vector pVL1392

(Invitrogen).

The pUC19BTV13M1 plasmid was digested with Pst I and
resolved on a 1% low-melting agarose gel.

After

electrophoresis, the band corresponding to the size of M1
gene was excised from the gel, the gel slice was melted and
ligated to Pst I-digested and CIP-treated pVL1392
expresslon vector, as described in Chapter II.

The

orientation of the recombinant plasmid carrying BTV-13 M1
gene was confirmed by BamH I restriction enzyme digestion.
The recombinant plasmid for transfection into insect cells
was purified according to Kraft et al.
purified by polyethylene glycol

(1988) and further

(PEG) precipitation. To

produce BTV-13 M1 mRNA for in vitro transcription and
translation, the BTV-13 M1 gene was cloned into pGEM4Z
(pGEM4ZBTV13M1) using the same procedures.

A mutant, ln

which the leucine-zipper region was deleted, was
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constructed by digesting pGEM4ZBTV13M1 with Xba I.

This

enzyme cut at nucleotide positions #1409 and #1734 inside
the BTV-13 M1 eDNA, and at nucleotide #34 inside the pGEM4Z
vector.

After digestion, the reaction mixture was resolved

on a 1% low-melting point agarose gel.

Two fragments

without the leucine-zipper coding reg1on (1.4 kb and 3 kb)
were excised from the gel and ligated to each other.

The

orientation of the insert was checked by Kpn I restriction
enzyme digestion.

This leucine-zipper deleted mutant had

an internal deletion between bases #1409-1733

(amino acid

residues #468-575), and was in-frame to the C-terminal
coding region.
Construction of recombinant
plasmids and 3'-deletion
mutants for express~on
~n E. coli
The full-length eDNA of the BTV-13 M1 gene was
amplified from the dsRNA genome of BTV according to the
.
method described in Chapter II. A pair of primers
containing the sequences of 5'-GACGTCGACCCGGGGATGCCTGAGCCA
-3'and 5'-GACGTCGACCCGGGTAAGTTGTACAT-3'

(the sequences of

the BTV M1 gene are underlined) was used for amplification,
and the eDNA was cloned into the pTrxFus
expression vector at the Sma I site.

(Invitrogen)

This enzyme removed

the 5' non-coding reg1on (eight bases), and fused the
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remalnl n g M1 eDNA in-frame to the reglon coding for
thio redoxin.

In this expression system, the target

proteins are expressed as thioredoxin (Trx)
proteins.

fusio~

The recombinant plasmids were transformed into

E. coli GI698 or GI724

(Invitrogen) by electroporation

(Gene Pulser™, Bio-Rad, settings of 25 pF, 2.5 kV, 200 Q,
4 msec) .

The orientation of the insert was determined by

BamH I enzyme digestion.
The pTrxBTV13 plasmid was used for constructing the 3'
deletion mutants of the M1 gene with the Erase-A-Base kit
(Promega).

Because exonuclease III

(Exo III) will digest

the nicked DNA, supercoiled plasmids are required to
construct deletion mutants.

To purify supercoiled

plasmids, acidic phenol extraction was used.

An overnight

E. coli culture (200 ml) was centrifuged at 2000x g for 10

mln.

The E. coli pellet was resuspended ln 10 ml of lysis

buffer (25 rnM Tris-HCl, pH 8, 50 mM glucose, 10 mM EDTA, 5
mg/ml lysozyme) and incubated at room temperature for 5
min.

A total of 20 ml 0.2 N NaOH and 1% SDS mixture was

then added to the solution and incubated on lee.

After 10

min incubation, 12.5 ml of saturated ammonium acetate was
added to the solution, and gently mixed for 30 sec,
followed by an additional 10 min incubation on 1ce.

The

solution was then centrifuged at 12,000x g for 10 min at
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4°

c.

The supernatant was passed through a glass-wool

plugged

fun~el

into a centrifuge bottle.

Seven-tenths

volume of ice-cold isopropanol was added to the filtrate,
mixed, and kept on ice for 20 min.

DNA was recovered by

centrifugation at 12,000x g for 15 min at 4° C.

The DNA

pellet was then dissolved 1n 6 ml of acidic extraction
solution (0.75 M NaCl, 10 mM EDTA,
4.2), and kept on ice for 5 min.

0.3 M sodium acetate, pH
An equal volume of water-

saturated phenol was added to the DNA solution, vortexed
for 1 min, and centrifuged at 12,000x g for 10 min at 4° C.
The top layer was discarded and the acidic extraction was
repeated once.

.

The organic phase was then mixed with 3.5

ml of reverse extraction buffer (1.5 M Tris-base, 5 mM
EDTA)

and 3.5 ml of chloroform.

After centrifugation, the

top layer containing the supercoiled plasmids was removed
to a new tube and extracted once with an equal volume of
chloroform.

The supercoiled plasmids were then

precipitated by addition of 0.1x volume of 3 M sodium
acetate, pH 4.2, and 0.7x volume of ice-cold isopropanol.
The plasmids were recovered by centrifugation at 4,000 rpm
for 15 min at 4° C and washed twice with 70% ice-cold
ethanol.

The super-coiled plasmid DNA pellet was then

dried and dissolved in TE.

80
To construct the deletion mutants, the supercoiled
plasmids were digested with Pst I and Nco I restriction
enzymes to create an Exo III (Promega) resistant 3'overhang end (within the expression vector) and a 5'unprotected end (3'-end of the M1 gene)
plasmids.

in the linearized

The linearized plasmids were analyzed by gel

electrophoresis to confirm that digestion was completed,
then purified by phenol/chloroform extraction as described
in Chapter II.

The linearized plasmids (5 pg) were

dissolved ln 60 pl of Exo III buffer (66 mM Tris-HCl, pH
8.0, 0.66 mM MgCl 2) and then digested with 300 units of Exo
III at 15° C.

At every 30-sec interval, 2.5 pl of the

reaction mixture were transferred to a tube containing 7.5
pl of S1 nuclease mixture (2 units S1 nuclease, 40 mM
potassium acetate, pH 4.6, 333 mM NaCl, 1.25 mM ZnS0 4 ,
6.75% glycerol) and kept on ice to stop the Exo III
digestion.

At the end of sample collection, the DNA

samples were incubated at room temperature for 30 min to
start the S1 nuclease digestion, to remove the singlestranded tails left after the Exo III digestion.

One pl of

S1 nuclease stop buffer (0.3 M Tris base, pH 10, 0.05 M
EDTA) was added, followed by heating at 70° C for 10 min to
inactivate the S1 nuclease.

One pl of Klenow mixture (100

u/ml of Klenow DNA polymerase, 20 mM Tris-HCl, pH 8.0, 100
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mM MgCl 2) was added to the reaction mixture and incubated

for 5 min at 37 ° C, before 1 pl of dNTP mixture (0.125 mM
each of dATP, dCTP, dTTP, dGTP) was added to generate blunt
ends for ligation.

The ligation mixtures were then used to

transform E. coli strains GI698 and GI724, and the
transformed E. coli was selected on agar plates with
ampicillin. The deletions were confirmed by DNA sequenclng,
and expression of the truncated proteins was confirmed by
immunodetection with antibodies.
Expression and purification of
VP4 in the recombinant
baculovirus system

Insect cells were grown and maintained as described by
Johnson and Li

(1991).

Co-transfection with the

recombinant pVL1392BTV13M1 plasmid and linear baculoviral
DNA (Baculogold™) was performed according to the
manufacturer's protocol (PharMingen).

A monolayer of SF-9

cells grown in Grace's medium with 10% fetal bovine serum
or High-S™ cells grown in serum-free Excel 405 medium
(J.R. Scientific) at 80% confluence were infected with
recombinant baculovirus carrying the BTV-13 M1 gene at a
multiplicity of infection (M.O.I.) of 10 to 20.

After 72

hr postinfection, the insect cells were centrifuged
(Beckman GPR Centrifuge) at 1,000 rpm for 10 min, and the
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cell pellets were washed with phosphate-buffered saline
(PBS).

The cell pellets were resuspended in STE (10 mM

Tris-HCl, pH 8, 1 mM EDTA, and 150 mM NaCl) and lysed by
sonication (VirSonic, 80% power output) three times
each) at 0° C.

(10 sec

Recombinant VP4 was identified by comparing

the cell lysate to mock-infected cells with both SDS-PAGE
and immunodetection.

VP4 was found mainly in insoluble

form due to aggregation.

The insoluble VP4 was pelleted by

centrifugation at 4,000 rpm for 15 min at 4° C.

Because of

the high yield of VP4, a major portion of the pellets was
composed of VP4.

Insoluble VP4 was dissolved at a final

concentration of 0.3 mg/ml in STE containing 5 mM
dithiothreitol

(DTT), 0.15% N-lauroyl sarcosine, and 0.01 %

Triton X- 100 (TX - 100).

After 30 min of incubation at room

temperature, insoluble materials were removed by
centrifugation at 4,000 rpm for 30 min.

The soluble VP4 ln

the supernatant was then dialyzed against STE with 0.05 % Nlauroyl sarcosine, 0.01% TX-100, and 10 mM reduced
glutathione for 5 hr at 4° C.

The dialysis buffer was then

changed to STE with 0.01% TX-100 and 5 mM reduced
glutathione and dialyzed overnight at 4° C.

The dialyzed

protein solution was then centrifuged at 4,000 rpm for 30
min at 4° C to remove any aggregated protein.

The

dialysate was passed once through a Sephadex G-75
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(Pharmacia)

sizing column pre-equilibrated with STE.

The

soluble VP4 was found in the void volume and the low
molecular weight cellular proteins were retained in the
column.

VP4 was further purified through a 5 to 50%

(w/v)

discontinuous sucrose gradient with a cushion of 66%
sucrose (w/w)

in STE.

After centrifugation at 30,000 rpm

(Beckman LS-70 Ultracentrifuge)

for 1.5 hr at 4° C in a

SW41 rotor, VP4 was located at the interface of the 50% and
66 % sucrose solution.
Expression of VP4 in E. coli
The full-length and 3'-end deleted Ml genes cloned
into the expression vector pTrxFus were transformed into E.
coli strain GI698 or GI724 by electroporation as previously
described.

The expression procedures from the manufacturer

(Invitrogen) were followed.

An overnight culture of E.coli

in RM medium (1x M9 salt, 2% casamino acid,
1mM MgC1 2 ,

1% glycerol,

100 pg/ml ampicillin) was grown at 30° C and

diluted 20-fold with the induction medium (1x M9 salt, 0.2%
casamino acid,
· ampicillin).

0.5% sucrose, 1rnM MgCl 2, 100 pg/ml
After 2.5 hr of shaking at 30° C, tryptophan

was added to the culture at a final concentration of 100
~g/ml

as an inducer.

The temperatures for VP4 expression

in E. coli GI698 and GI724 were 30° C and 37° C,
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respectively.

At 3.5 hr postinduction, the E. coli cells

were harvested, lysed, and analyzed by gel electrophoresis
and by immunodetection.
Production of oligoclonal and
monoclonal antibodies

The locations of potential antigenic epitopes of VP4
were predicted using the PlotStructure Program in the GCG
software (Genetic Computer Group, 1994).

Six synthetic

peptides synthesized in the multiple antigen peptide format
were used as immunogens to produce oligoclonal antibodies
(OAbs) against VP4

(Li and Yang, 1990; Yang et al., 1992;

Huang et al., 1995).

The positions of these six peptides

were residues: #617-626 (RALREYKRKM), #583-592
(KEQKLRDLKR), #167-178

(GARFDDEPTDEK), #376-385

(RDRGTFLKKR), #103-115 (ENEIGRRRIRMRK), and #523-551
(RVESSVLRVRNPTLHETADELKRMGLDL) .

The corresponding OAbs are

designated as OAb #76, 77, 78, 80, 81, and 82,
respectively.

Rabbits were immunized intramuscularly with

0.5 ml of the peptide solution (100 pg of each individual
peptide resuspended in PBS) mixed with an equal volume of
Complete Freund's Adjuvant (Sigma).

Booster injections

followed every 3 weeks with a mixture of antigen and
Incomplete Freund's Adjuvant (Sigma).

Between each booster

injection, 10 ml of sera were collected from the rabbits

85

for analysis of the antibody titers.

After the fourth

booster, rabbits were bled, and the antisera were collected
and pooled for immunodetections.

Recombinant VP4 expressed

in insect cells was used os an antigen to produce anti-VP4
monoclonal antibodies

(MAbs) by the Biotechnology Center at

Utah State University.

The anti-VP4 MAbs (D3.6.24 and

D3.10.1) were determined to be the IgM isotype.
Enzyme-linked immunosorbent
assay (ELISA)

ELISA us1ng OAbs and MAbs was carried out as described
by Yang et al.
VP4 proeins

(1992) with some modifications.

(5 pg)

Purified

in 50 pl of 10 mM sodium carbonate, pH

9.6, were immobilized overnight at 4° C to the bottom of a
96-well plate (Dynatech) .

The plate was washed six times

with PBS containing 0.05% Tween-20 (Sigma)

(PBS-T), and

blocked with 200 pl of 3% bovine serum albumin (BSA)
PBS-T for 1 hr at 37 ° C.

in

The plate was washed with PBS-T

aga1n before antibodies were added to the wells.

The

antibodies were diluted at 1:10, 1:100; 1:1,000, and
1:10,000 in PBS-T for the assay.

After 90 min of

incubation at room temperature, the plate was washed four
times with PBS-T to remove the unbound antibodies.

Second

antibodies (alkaline phosphatase(AP)-conjugated goat antirabbit IgG or AP-conjugated goat anti-mouse IgM antibodies)
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were added to the wells at 1:10,000 dilution and incubated
at 37 ° C for 1 hr.

The plata was then washed with PES-T 4

times and another four times with AP developing buffer (100
mM Tris-HCl, pH 9.5, 5 mM MgC1 2 ,

100 mM NaCl).

The color

reaction was developed with the addition of AP substrate,
p-nitrophenyl phosphate, disodium (pNPP)
developing buffer mixture.

(Sigma)

in the AP

The extent of binding was

measured in triplicate at 405 nm by an ELISA reader
(Dynatech) .

SDS-PAGE and immunodetection
The protocols used for SDS-PAGE and immunodetection
were similar to those routinely employed in our laboratory.
Briefly, proteins were separated on a discontinuous SDSPAGE using the method of Laemmli

(1970) and transferred to

two nitrocellulose membranes by a diffusional sandwich
technique,

in buffer containing 25 mM Tris-HCl,

glycine, and 20%

(v/v) methanol.

192 mM

The epitope analyses by

immunodetection were carried out as previously described by
Li and Yang (1990).

Immunoblocking assay by
synthetic peptides
Each of the synthetic peptides

(50

~g)

dissolved in

PBS was mixed with 20 pl of ascites fluid and incubated for
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2 hr with constant agitation at 37 ° C.

The MAb incubated

with PBS only (without any peptide) was used as a positive
control.

After a brief centrifugation, the cross-absorbed

MAbs in the supernatant were used for immunodetection
(1:400 dilution)

against recombinant VP4 in SF-9 cell

lysate in Western blot analyses.

The loss of reactivity

with VP4 indicated the possible location of the epitope.

In vitro transcription and
translation of mRNA
of Ml gene
The pGEM4Z vectors carry1ng the full-length BTV-13 M1
gene or the leucine-zipper deleted mutant were linearized
with Sma I, and RNA transcripts were synthesized using T7
RNA polymerase.

The reactions were carried out in the

presence or absence of an RNA-cap analog (BRL) .
non-capped mRNA,

For making

6 pg of linearalized plasmids were

incubated in a final volume of 100 pl reaction mixture
containing 40 mM Tris-HCl, pH 7.5,

6 mM MgCl 2, 2 mM

spermidine, 10 mM NaCl, 0.5 mM of each rNTP, and 50 units
of T7 RNA polymerase at 40 ° C for 1.5 hr.

For making

capped mRNA, 0.5 mM of RNA cap analog (BRL) and 0.05 mM
rGTP were used to replace the 0.5 mM rGTP in the reaction
mixture.

The synthesized mRNA should have more than 90%

capped mRNA using the in vitro transcription kit with RNA
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cap analog (BRL), according to the manufacturer. At the end
of the reaction,

the DNA templates were digested with DNase

(BMB) and the RNA transcripts were extracted with phenolchloroform and precipitated with ethanol.

An amount of

transcript (0.3 pg) dissolved in H2 0 was used for in vitro
translation with 25 pl of wheat germ extract (Promega), 4
pl of 1mM amino acids mixture (without methionine)
(Promega), 1 pl of RNase inhibitor (100u/pl)

(USB), and 2.5

pl of [ 35 S]-methionine (10 mCi/ml)

in a 50-pl

(Amersham)

reaction mixture, at 25° C for 2 hr.

Before mixing the

mRNA with the translation mixture, the template mRNA was
heated at 67 ° C for 10 min and chilled on ice immediately
to destroy local regions of secondary structure.

The

amount of rnRNA used for in vitro translation was optimized
and found to be 0.06 pg per 10 pl of reaction.

The

translation mixtures were centrifuged for 5 min at 4° C ln
a microcentrifuge before subsequent analyses.

Poly(U)-Sepharose 4B affinity
chromatography
Ten pl of the in vitro translated intact or truncated
VP4 proteins were diluted with 200 pl of TE (10 mM TrisHCl, pH 8, 1 mM EDTA) and

applied onto a 0.6 ml poly(U)-

Sepharose 4B column (Sigma) pre-equilibrated with TE.

The

column was then washed with TE until no radioactivity was
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detected ln the flow-through fractions, monitored with a GM
counter.

The bound VP4 proteins were eluted with a step

gradient of 0.15 , 0.5, and 1.5 M NaCl in TE (pH 8).

The

eluants were precipitated by 10% trichloroacetic acid
(TCA), with 10 pg of bovine serum albumin (BSA)
carrier, at 0° C for 20 min.

as a

After centrifugation at

10,000x g for 10 min, the pellets were washed with 70%
ethanol or acetone and dried at 37 ° C.

The pellets were

dissolved in 15 pl of SDS-PAGE sample buffer and boiled for
3 min before SDS-PAGE analysis.

Pre-stained protein

markers were used as molecular weight references.

At the

end of electrophoresis, the gels were dried under vacuum at
80° C and exposed to X-ray film for autoradiography.
RNA probes preparation

Both capped and non-capped [ 3 2 P]-labeled BTV M1 ssRNAs
were in vitro transcribed as described above except that
[a- 32 P]-rGTP (15 pCi/ml) was included in the reaction
mixture.

Nonradioactive RNA probes were labeled with

biotin (BRL) .
Electrophoretic mobility
shift assay (EMSA)

Secondary structures of the ssRNA were initially
disrupted by incubating at 70° C for 10 min and chilling on
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lee immediately.

Various amounts of purified VP4 ln STE

were incubated with 28 ng of [ 32 P]-ssRNA at room
temperature (about 22 ° C)

for 20 min in a reaction buffer

containing 10 1nM Tris-HCl, pH 8, 1 mM EDTA, and 60 mM NaCl.
The protein-RNA complexes were resolved on a 0.8% agarose
gel

(0.5x TEE buffer) at 100 V until the bromophenol blue

dye front reached the bottom of the agarose gel.

The gels

were fixed with 10% methanol and 10% acetic acid for 15 mln
and dried between two sheets of BioGel wrap membranes
(BioDesign) at 37 ° C prior to autoradiography.

Northwestern Assay
Various amounts of sequence-specific peptides were
dot-blotted to a nitrocellulose membrane.

The membrane was

then washed with 0.1x STE buffer and incubated with [ 32 P]ssRNA for 30 mln.

The membrane was washed with the same

buffer three times (10 min each), air dried, and used for
autoradiography.
To develop the Northwestern assay using a biotinylated
RNA probe, the nitrocellulose membrane was first blocked
· with 3% BSA in binding buffer for 1 hr,

followed by adding

the RNA probes to the binding solution and incubating for
30 min.

The bound RNA probes were detected with avidin-

conjugated horseradish peroxidase (HRP) .

The color

91
reaction was developed in 10 ml of developing solution (0.6
mg/ml o f diaminobendizine ln 9 mM Tris-HCl,

0.03 % CoCl 2,

For the mapping of RNA-binding domain uslng truncated
Trx-VP4 fusion proteins, proteins were separated on SDSPAGE and transferred overnight at room temperature in
transfer buffer (25 mM Tris-HCl, pH 8.3, 192 mM glycine,
20 % methanol)
1990 ) .

to nitrocellulose membranes (Li and Yang,

The proteins were allowed to "renature" by washing

membranes in binding buffer (10 mM Tris-HCl, pH 8, 50 mM
NaCl,

1

mM

EDTA, and 1x Denhardt's solution) at room

temperature for at least 1 hr with three changes of buffer.
[

32

P] -labeled RNA probes were added to 10 ml binding buffer

and incubated with the nitrocellulose membrane containing
the transferred proteins at room temperature for 1 hr.

The

membrane was then washed with binding buffer three times
for 5 min each.

The membrane was then air dried and

exposed to X-ray film for autoradiography.
Chemical cross-linking of
VP4 protein

In vitro translated VP4 proteins (3 pl) were diluted
with 87 pl of cross-linking buffer (20 mM HEPES, pH 8, 150

mM NaCl, 1 mM EDTA) to a final volume of 90 pl.

Cross-

linking was initiated by the addition of 10 pl of 0.1%
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glutara l dehyde (50% EM grade, Sigma).

At predetermined

times of incubation at room temperature, the cross-linking
reactions were terminated with the addition of 100 pl of
1 M glycine.
0°

c

Proteins were precipitated with TCA (10%) at

for 20 min with 10 pg of BSA as a carrier.

Precipitants were washed with cold acetone were resuspended
in SDS-PAGE sample buffer, then resolved on a 3.5% SDS-PAGE
(1.5 rom thickness) gel prepared according to Sigma
Technical Bulletin (MWS-877).

Proteins were separated by

electrophoresis at 50 rnA (room temperature)

for 13 hr.

At

the end of electrophoresis, the gel was stained by
Coomassie blue and destained to visualize and locate the
molecular weight markers.

The gel was then dried under

vacuum (80 ° C) and used for autoradiography.

Cros~-linked

phosphorylase b proteins (Sigma) were used as molecular
weight markers.
RESULTS

Production and purification
of recombinant VP4
~n insect cells

SF-9 or High-5 cells infected with recombinant
baculovirus carrying the BTV-13 M1 gene expressed high
levels of VP4.

The recombinant VP4 had a molecular weight

close to 75 kDa as determined by SDS-PAGE.

This molecular
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weight is similar to that predicted from the deduced am1no
acid sequence (Huang et al., 1993) and to the VP4 in
purified BTV virions.

The level of VP4 expression was

M.O.I.-dependent (Lane 1 and 2, Fig. 6A).

The identity of

the expressed VP4 was confirmed on a Western blot by
immunodetection using a polyclonal antibody against BTV
virions (Fig. 6B and C).

The bulk of recombinant VP4

expressed in insect cells was insoluble even though VP4 has
a high content of charged and polar amino acid residues
(Huang et al., 1993).

This was also true when VP4 was

expressed as thioredoxin (Trx)-VP4
glutathione-S-transferase (GST)-VP4
histidines (6xH)-VP4

(Qiagen)

(Invitrogen),
(Pharmicia), and six

fusion proteins in different

strains of E. coli and under different induction conditions
(data not shown).

Many conditions were employed in the

attempt to purify a large quantity of VP4 for structure and
function analyses.
produce soluble VP4.

Unfortunately, no method worked to
These methods, which are summarized

in Appendix D, have been tried and investigated without
success.

However, the insoluble VP4 was solubilized

successfully upon treatment with STE buffer containing
0.15% N-lauroyl sarcos1ne, 5mM DTT, and 0.01% TX-100.

The

detergents were removed by stepwise dialysis, which allowed
the VP4 protein to be maintained in its soluble form.

The
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optimal VP4 concentration for refolding and renaturation
was 0.3 mg/ml.

Concentrations higher than 0.3 mg/ml

resulted in rapid precipitation to an insoluble form.

VP4

was further purified to near homogeneity by a sizing column
and sucrose gradient (Fig. 7).

Because VP4 formed an octa-

meric structure at a molecular weight of 600 kDa (see
below), the VP4 oligomer was in the void volume during
elution from the Sephadex G-75 sizing column.

The VP4

oligomers could be separated from other proteins by discontinuous sucrose gradients.

The VP4 oligomers were found at

the interface of 50% (w/v) and 66%

(w/w) sucrose solutions

after ultra-centrifugation at 110,000x g for 1.5 hr.
Identification of the antigenic
epitopes of VP4

To identify and map the linear antigenic epitopes of
VP4, potential antigenic epitopes of the cognate VP4 were
predicted by the GCG computer package.

Six oligopeptides

were synthesized in the multiple antigen peptide (MAP)
format

(Tam, 1988; Li and Yang, 1990; Yang et al., 1992

Huang et al.,

1995) and then used to produce six OAbs

#76, 77, 78, 80, 81, and 82) in rabbits.

(OAb

The OAbs were

analyzed by immunodetection on Western blots (Fig. 8) and
ELISA (Fig. 9).

In Western blot immunodetection as shown

in Fig. 8, OAb #78, 81, and 82 reacted well with VP4 at
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1:1,000 dilution; OAb #80 had a moderate reactivity at
1:500 dilution; OAb #76 and 77 had a very limited
reactivity even at 1:250 dilution.

These results are

evidence that amino acid residues between #617-626 (RALREYK
RKM),

#583-592

(KEQKLRDLKR), #167-178

(GARFDDEPTDEK),

#376-

385 (RDRGTFLKKR), #103-115 (ENEIGRRRIRMRK), and #523-551
(RVESSVLRVRNPTLHETADELKRMGLDL) represent linear epitopes or
major linear components of conformational epitopes of VP4.
To determine whether these antigenic epitopes are
surface accessible, an ELISA was carried out using these
six OAbs against purified VP4
OAbs #76,

78,

(Fig. 9).

In ELISA tests,

81, and 82 had strong reactions with the

native and intact VP4, and OAb #77 and 80 had weaker
reactivities.

These results are evidence that the

antigenic domains corresponding to the sequences of
peptides #76, 77, 78, 80,

81, and 82 are potential linear

epitopes on the surface of VP4.

OAb #76 had a very weak

reactivity against the denatured VP4 on a Western blot
(Fig. 8), but had a strong reactivity against native VP4 1n
ELISA (Fig. 9).

This implied that the conformation of this

region is important for the reaction with OAb #76.
Monoclonal antibodies against VP4

(D3.6.24 and

D3.10.1) were produced for an attempt to map conformational
epitopes (Fig. 9 and 10).

To identify the location of
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these conformational epitopes, an epitope-scanning approach
(Hwang and Li, 1993) with sequence-specific synthetic
peptides was used to block binding of MAbs towards VP4 on a
Western blot (Fig. 10).

The two MAbs in ascites fluid were

incubated with 50 pg of each synthetic peptide (#76, 77,
78, 80, and 81) individually at 37° C for 2 hr with
constant agitation.

The cross-absorbed ascites fluids were

then used for immunodetection on a Western blot (Fig. 10).
As shown in Fig. lOA, peptides #76,
binding of MAb D3.6.24 to VP4.

80, and 81 blocked the

Since the locations of

peptides #76 (residues #617-626), #80 (residues #376-385),
and #81

.

(residues #103-115) are located in different

reglons of VP4, this suggests that the antigenic epitope
defined by MAb D3.6.24 is a conformational determinant.
shown in Fig. lOB, only peptides #76 (residues #617-626),
and #81

(residues #103-115) blocked the binding of MAb

D3.10.1 to VP4.

These results are evidence that the

epitope recognized by MAb D3.10.1 is conformational and
were also consistent with the results of ELISA that
peptides #76, 80, and 81 are surface accessible.
Nucleic acid binding
activity of VP4
VP4, a GTP-binding protein, lS a candidate for being
the guanylyltransferase of BTV (Le Blois et al., 1992). A

As

97

potential leucine-zipper motif and a stretch of charged
amino acid residues upstream of the zipper region were
identified from the deduced amino acid sequences of five US
BTV VP4 proteins (Huang et al., 1993).

These features are

found in many nucleic acid binding proteins.

The proposed

guanylyltransferase activity of VP4 suggested that this
protein may be a ssRNA-binding protein.

Therefore, the

ssRNA-binding activity of VP4 was investigated.
As shown in Fig. 11A, the binding of VP4 to the BTV
ssRNA resulted in retardation of the migration of the
labeled RNA transcripts in gel electrophoresis.

The amount

of RNA retarded in EMSA was proportional to the amount of
VP4 added to the reaction mixture. When non-labeled, noncapped RNA transcripts were added to the RNA-binding
reaction mixture, the amount of labeled, retarded RNA
transcripts was inversely proportional to the amount of
added non-labeled RNA.

This is evidence that the binding

of VP4 to ssRNA was not dependent on the cap structure of
the transcript (Fig. 11B).

The specificity of VP4 ssRNA-

binding activity was also determined by competition with
unlabeled yeast tRNA.

As shown in Fig. 12, the labeled

ssRNA transcripts were not retarded · when 500 pg of
unlabeled yeast tRNA was added to the reaction mixture.
Upon the addition of 1% SDS to the reaction mixture, VP4
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aborted the RNA-binding activity (Lane 5, Fig. 12).

This

is evidence that the nondenatured form of VP4 is required
for RNA-binding.

The identity of RNA was confirmed by

incubating the RNA with RNase A in 60 mM NaCl.
was digested by this nuclease treatment (Lane 6,

The ssRNA
Fig. 12).

Because the leucine-zipper motif is involved in
nucleic acid binding activity of some proteins (Perutz,
1992), the role of the VP4 leucine-zipper motif in the RNAbinding activity was investigated.
truncated VP4

(VP4~LZ),

The intact and the

which has an internal deletion of

the leucine-zipper region, were translated in vitro (Fig.
13B), and their RNA-binding activity toward poly(U)sepharose was tested.

In vitro translated VP4 was able to bind to poly(U)sepharose (Fig. 3A).
at pH 8.

VP4 was eluted with 0.15 M NaCl in TE

The deletion mutant without the leucine-zipper

motif was also able to bind to the poly(U) in the sepharose
column (Fig. 14B).

These results are evidence that the

leucine-zipper motif within the VP4 protein is not required
for the RNA-binding activity.
Mapping the ssRNA-binding
domains of VP4

To locate the RNA-binding domain of VP4, a series of
C-terminus deleted VP4 proteins were constructed by
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deleting the 3'-end of the Ml gene ln the pTrxVP4 plasmid
(see MATERIALS AND METHODS).

These C-terminal truncated

VP4 proteins were expressed as thioredoxin (Trx)
proteins.

Trx-VP4 and most of the

tr~ncated

fusion

Trx-VP4

mutants were expressed as an insoluble form.

Nucleic acid

binding on protein blots has been used to identify DNA(Bowne et al., 1980; Hoch, 1982) and RNA-

(McCormack et

al., 1992; Labbe et al., 1994) binding proteins.

Since it

is difficult to purify the insoluble Trx-VP4 truncated
protein for the RNA-binding assay in EMSA,

I used a similar

technique to detect the RNA-binding domain of VP4 on
protein blots (Northwestern assay) .

To determine whether

the VP4 expressed in E. coli retained RNA-binding activity,
a Northwestern assay was carried out using VP4 expressed
both in insect cells and in E. coli

(Trx-VP4).

The VP4

expressed in insect cells was used as a positive control.
As shown in Fig. 15, the VP4 proteins expressed in both
systems have ssRNA-binding activity.

The RNA-binding

efficiency of VP4 in the Northwesterr. assay was not
equivalent to the amount of protein on the membrane, but
might result from different renaturing efficiencies of VP4
on membranes.

The ssRNA-binding capability of VP4 on the

protein blot was also sensitive to 0.15 M NaCl.

When an

RNA-bound protein blot was washed with TBST (10 mM Tris-
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HCl, pH 8, 150 mM NaCl, 0.3 % Tween-20), the bound RNA was
released from the protein (data not shown).

This result

corresponded to that obtained from the poly(U)-sepharose
column (Fig. 14).

The same technique was also used to map

the RNA-binding domains on protein blots with Trx-VP4 and
truncated VP4 proteins.

The identities of Trx-VP4 and the

truncated VP4 proteins were confirmed by anti-VP4 OAbs
(Fig. 16).
The truncated mutants

~1B

and

~58,

which have only

amino acid residues #1-111 and #1-76, respectively, lack
ssRNA-binding activity (Fig. 17).
truncated mutant

~81,

In contrast, the

which has am1no acid residues #1-

158, and all other mutants were able to bind to labeled
ssRNA.

An interpretation is that a ssRNA-binding domain 1s

located between amino acid residues #112-158.

To determine

if residues #112-158 represent the only ssRNA-binding
domain, an N-terminal truncated Trx-VP4 was constructed
(mutant

~67),

which deleted amino acid residues #1-298.

The identity of mutant
seen in Fig. 16, mutant

~67

~67

was confirmed by OAb #82.

As

was not able to react with OAb

#81, which recogn1zes the N-terminus of VP4, but did react
with OAb #82, which recognizes the C-terminus of VP4.
seen in Fig. 17, mutant

~67

retained ssRNA-binding

As

activity.
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This result lS evidence that there lS at least

one more ssRNA-binding domain of VP4, in the region between
residues #299-644, in addition to the one located in the
#112-158 reglon.
Many studies have shown that RNA-binding domains
contain clusters of basic amino acid residues (Merrill et

al., 1988; Lazinski et al., 1989; Nagai et al., 1990; Lee
et al., 1993; Waksman et al., 1993; Hayama and Li, 1994).
Many lysine and arginine clusters are found in VP4, which
could function as RNA-binding sites.

In the studies of BTV

VP6, Hayama and Li (1994) used sequence-specific peptides
to map the RNA-binding domains of VP6.

A similar technique

was used to map other RNA-binding domains of VP4.
Peptides of VP4, 9 to 13 residues ln length, were used
ln EMSA and Northwestern assays to map ssRNA-binding
domains. As shown in Fig. 18, peptides #76, 77, 80, and 31
retarded ssRNA in EMSA and bound ssRNA on the membrane in
the Northwestern assay.
affinity.

Peptide #77 has a lower binding

Peptide #78 has no ssRNA-binding activity in

either the EMSA or Northwestern assay.

Therefore, these

four regions represented by the peptides are the potential
ssRNA-binding domains of VP4.

The binding ability of these

peptides to dsDNA and dsRNA of the BTV genome was
investigated.

We found that the same peptides that bind to
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ssRNA were able to bind to BTV dsRNA, and none of the
peptides was able to bind dsDNA (data not shown) .

Thus,

t hese pept i des have specific binding activity to RNA
instead of to any type of nucleic acids.
Translational efficiency of
capped and non-capped
Ml mRNA

It ls assumed, but has not been proven, that BTV mRNAs
are capped.

I decided to investigate whether the cap

structure of the BTV mRNA is required for translation and
whether capped and non-capped BTV mRNAs synthesized in

vitro have different translational efficiencies.

Both

capped and non-capped BTV-13 M1 mRNAs were transcribed as
described in Materials and Methods.

These mRNAs w_ere used

for in vitro translation with wheat germ extracts
(Promega).

As shown in Fig. 13A, equal amounts of both

capped and non-capped BTV M1 mRNA (0.06 pg)

in 10

~1

of the

wheat germ translation mixture had a similar efficiency of
translation.

This result implies that the cap structure of

BTV mRNA is not required for translation (at least not ln a
wheat germ system).

The in vitro translated VP4 was

.

soluble, and it was found in the supernatant fraction after
centrifugation at 10,000x g for 10 min (data not shown).

103
Oligomerization of VP4

Leucine-zipper motifs are known to be responsible for
protein dimerization (Landschulz et al., 1988) and
trimerization (Sorger and Nelson, 1989).

Therefore, the

possibility that VP4 forms an oligomer through its leucinezipper was investigated.

In vitro translated VP4 labeled

with [ 35 S]-methionine was incubated with glutaraldehyde for
varlous times.

After the chemical cross-linking, the

product was resolved by SDS-PAGE and examined by
autoradiography.

As shown in Fig. 19, in the presence of

cross-linker and increased incubation time, the amount of
VP4 monomer (75 kDa) decreased and the amount of oligomeric
protein increased.

By comparison with known size markers,

the molecular weight of the VP4 oligomer was estimated to
be around 600 kDa.

This is evidence that VP4 forms a high

molecular weight oligomer, probably an octamer in solution.
In the Coomassie blue stained SDS-PAGE that separated the
chemically cross-linked products, most of the translation
factors were not cross-linked.
cross-linking was specific.

This is evidence that the

Since the oligomerization of

Hsp104 of Saccharomyces cerevisiae is affected by the
presence of ATP (Parsell et al., 1994), and VP4 is a GTPbinding protein (Le Blois et al., 1992), the effect of
ribonucleotides

(rNTP) on VP4 oligomerization was
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investigated.

Oligomerizatio n of VP4 was not affected by 1

mM of each individual rNTP in the cross-linking mixture
(data not shown) .
To investigate whether the leucine-zipper motif is
required for oligomerization, a cross-linking experiment
was performed using the leucine-zipper deleted mutant
(VP4~LZ).

In this case, another bifunctional cross-

linker, dimethyl suberimidate dichloride (DMS), was used
for the cross-linking reactions.

DMS is an imidoester

homobifunctional cross-linker that reacts with primary
amines on proteins and has a short spacer arm 11
length.

As shown in Fig. 20, when truncated

A in

VP4~LZ

was

exposed to increasing concentrations of DMS, the monomer
was converted into an oligomer.
that

VP4~Z

These results are evidence

is oligomeric in solution.

DISCUSSION
Each BTV virion has an estimated 5 to 10 molecules of
VP4 inside the inner core (Huismans and Van Dijk, 1990).
Although VP4 has been suggested to be the guanylyltransferase of BTV because of its GTP-binding activity (Le
Blois et al.,

1992), GTP-binding and capping activity have

not been demonstrated in purified VP4.

No other properties
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of this protein have been discussed.

In this report,

I

have expressed and purified recombinant VP4 protein to near
homogeneity, identified it as a RNA-binding protein, mapped
several RNA-binding domains and antigenic epitopes, and
demonstrated that VP4 exists as a high molecular weight
oligomer.
Recombinant VP4 expressed in insect cells using the
baculovirus expression system was mostly insoluble even
though it has a high content of hydrophilic amino acids
(Huang et al., 1993).

After the cells infected with

recombinant baculovirus carrying the Ml gene were lysed by
detergents, freeze and thaw cycles, or sonication, only
very small amounts of soluble recombinant VP4 were detected
by immunodetection (data not shown) .

The expression of

recombinant VP4 in insect cells started at 24 hr
postinfection.

The expressed VP4 aggregated rapidly and

became insoluble immediately after its synthesis (data not
shown) .

Expressing VP4 as a GST-VP4 fusion protein in

insect cells failed to increase the amount of soluble VP4
(data not shown) .

Co-expressing VP4 and another inner

minor core protein, VP6, did not increase the production of
soluble VP4

(Appendix C) .

the pHIL-Sl

(Invitrogen) yeast (Pichia pastoris) expression

vector.

The Ml gene was also cloned into

VP4 expressed in this system was fused with a
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secretion signal from acid phosphatase (PH01).

We expected

the expressed VP4 to be secreted into the growth media of
yeast.

However, the expressed VP4 aggregated in the yeast

and was never secreted into the growth media (data not
shown ) .
VP4 remained ln insoluble aggregates when expressed in
different strains of E. coli as GST-VP4 and Trx-VP4 fusion
proteins.

These fusions often increase the solubility of

the expressed protein.
(6xH)

By expressing VP4 as 6-histidine

tagged fusion proteins, VP4 was purified in the

denatured state using a metal affinity column in the
presence of urea (Appendix B) .

.

When VP4 was expressed at

15° C, more soluble proteins were produced.
yield was reduced tremendously.

However, the

After deleting 400 amino

acid residues from the C-terminus, VP4 was expressed in a
soluble form.
I took advantage of the fact that VP4 aggregates to
separate it from most of the cellular proteins by
centrifugation.

By using the anionic detergent N-lauroyl

sarcosine in the presence of DTT and TX-100,

I was able to

solubilize and dissociate the VP4 from the aggregcttes, and
let it refold to soluble form by dialysis.
fcrms an oligomer,

Because VP4

I was able to purify it to near
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homogeneity uslng a slzlng column and a discontinuous
sucrose gradient

(Fig. 7).

Six OAbs against VP4 were produced uslng VP4 peptides
predicted by the PlotStructure program of the GCG package.
These six OAbs have different reactivities against VP4 in
Western blots against denatured VP4
against native and soluble VP4
9)

(Fig. 8) and in ELISA

(Fig. 9).

The result

(Fig.

that all of the OAbs were able to bind to VP4 in its

native form ln ELISA is evidence that these epitopes are
located on the surface of the protein.
a very weak reaction to denatured VP4

OAb #76 (1:250) had
(Fig. 8) but had a

strong reactivity to the native VP4 in ELISA (Fig. 9).
This is evidence that the conformation of the peptide #76
region (residues #617-626)
to interact.

is important for this antibody

It ls difficult to conclude that this region

ls a conformational epitope, since this region is only 9
amino acid residues in length.
of peptides #76,

The surface accessibility

80, and 81 was confirmed by peptide

competition against two MAbs against VP4

(Fig. 10).

Because peptides #76, 80, and 81 were able to block the
binding activity of MAb D3.6.24 to VP4, and these regions
are located at different locations (residues #617-626,
#376-385, and #103-115), I hypothesize that MAb D3.6.24
recognizes a conformational determinant composed of three
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regions of the prlmary structure of VP4.
is supported by the ELISA results

This hypothesis

(Fig. 9) and lS

consistent with predictions of the PlotStructure program
(Fig. 21).
located.

All of the peptide regions are probably surface
The results of peptide blocking (Fig. 10) are

evidence that both termini of VP4 and the middle of VP4
might come together in its native state.
This is the first report to show that VP4 is a ssRNAbinding protein.

The ability of VP4 to bind ssRNA was

demonstrated using EMSA (Fig. 11), binding to poly(U)sepharose (Fig. 14), and Northwestern assay (Fig. 16).

The

ssRNA-binding activity of the purified recombinant VP4
could be competed out by unlabeled BTV ssRNA homologously
and by yeast tRNA heterologously (Fig. 12).

This is

evidence that the binding of VP4 to ssRNA is not sequencespecific.
Four potential RNA-binding domains were mapped uslng
truncated Trx-VP4 fusion proteins and sequence-specific
peptides for the RNA-binding assay (Fig. 17 and 18).

These

regions are located at amino acid residues #103-115
(ENEIGRRRIRMRK), #376-385 (RDRGTFLKKR), #583-592
(KEQKLRDLKR), and #617-626 (RALREYKRK).
surface accessible to VP4

These regions are

(Fig. 9 and 16) and are rich ln

basic amino acid residues (Rand K), which are found in
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many RNA-binding proteins

(MeYrill et al., 1988; Lazinski

et al., 1989; Nagai et al., 1990).
Two classes of eukaryotic and prokaryotic RNA-binding
proteins have previously been identified.

One contains the

RNA-recognition motif (RRM), which consists of 80 amino
acids with two conserved sequences, RNP-1 and RNP-2, of 8
and 6 amino acids, respectively (Bandziulis et al., 1989;
Mattaj, 1989).

The other one ls classified as the

arginine-rich motif (ARM)
1993) .

family (reviewed in Mattaj,

These RNA-binding proteins bind to RNA through

short, arginine-rich sequences (4 to 8 arginines in a
stretch of 10-20 amino acids). They have been found 1n some
RNA viruses (tat and rev protein of HIV-1), bacteriophages
(theN protein of bacteriophage lambda), and ribosomal
proteins

(Lazinski et al., 1989).

is sufficient for RNA recognition.

The ARM sequence itself
There is little

sequence identity among ARMs, and most of the ARM proteins
do not share a common structure.

The RNA-binding peptides

of VP4 are similar to the ARM family.

After three RNA-

binding domains were deleted, the truncated VP4 was still
able to bind to RNA (Fig. 17).

This is evidence that the

RNA-binding activity of VP4 dose not require the
coexistence of the four RNA-binding domains to be
functional.

A similar result was found in the BTV VP6
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protein.

Since there are multiple RNA-binding domains of

VP6, only one domain is sufficient for the RNA-binding
(H ayama and Li, 1994).

This is different in hepatitis

delta virus antigen (HDAg), which has two ARMs, and both
are required for the

RNA-b~nding

activity.

Deletion of

either one of these ARM sequences resulted in the total
loss of the in vitro RNA-binding activity of HDAg (Lee et

al., 1993).

Perhaps, each the different RNA-binding

domains of VP4 is involved in different functions, such as
RNA capping, encapsidation, transcription, or replication.
One RNA-binding domain of VP4 was mapped between amino
acid residues #112-158 that has four amino acid residues
(112-RMRK-115)

that overlap the RNA-binding peptide #81

(103-ENEIGRRRIRMRK-115)
mutant

#~1B

(Fig. 18).

However, the truncated

(amino acid residues #1-111) was not able to

bind the ssRNA (Fig. 17).
sequence 112-RMRK-115

lS

An interpretation

lS

that the

very important for the ssRNA-

binding of VP4.
Although a leucine-zipper motif
nucleic acid binding proteins, it

lS

lS

found in many

not required for

ssRNA-binding of VP4 (Fig. 14 and Fig. 17).

Similar

observations were found in the rotavirus VP2 protein (Labbe
et al.,

1994) and the reovirus sigma 3 protein (Miller and

Samuel, 1992).
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From the chemical cross-linking experiment
VP4 was identified as an oligomer in solution.

(Fig. 19),
In the case

of HDAg, oligomerization is required for RNA replication
(Xia and Lai,
(Lin et al.,

1992) but is not required for RNA binding
1990).

When VP4 proteins

wer~

cross-linked

with glutaraldehyde, only the VP4 monomer and oligomer
appeared (Fig. 19).

The same results were obtained with

other types of cross-linking agents [e.g. ethyl glycolbis(succinic acid) N-hydroxysuccinimide, dimethyl
pimelimidate dihydrochloride]

(data not shown) .

Reducing

the concentration of glutaraldehyde to 0.005% or the

.

reaction temperature to 0° C did not inhibit oligomer
formation

(data not shown) .

The VP4 oligomer was not able

to enter a native gel, but was able to enter the gel 1n the
presence of 0.1% SDS
mM NaCl,

(data not shown).

The addition of 400

16 mM B-mercaptoethanol, or 40% glycerol to the

protein mixture did not allow VP4 to enter the native gel.
This is evidence that the exclusion of VP4 ls not the
result of nonspecific interactions with other proteins.
Although the chemical cross-linking experiments established
that VP4 may be an octamer, more data have to be obtained
to confirm these results, such as gel filtration
chromatography and electron-microscopy using the purified
VP4.
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The leucine-zipper motif ls not required for VP4
oligomerization (Fig. 20).

A similar observation was also

found in measles virus (Buckland et al., 1992) and
Newcastle disease virus (NDV)

(Reitter et al., 1995).

The

leucine-zipper motifs of the measles virus and NDV fusion
proteins are not required for their oligomerization but are
essential for fusion.

Whether the leucine-zipper motif has

any function in VP4 is unknown.

In the deduced amino acid

sequences of BTV VP1 proteins, two leucine-zipper motifs
were identified (Huang et al., 1995).

Perhaps VP4

interacts with VP1 through the leucine-zipper motifs, and
forms a complex to regulate the transcription and
replication of BTV.
In the Northwestern assay, the VP4 monomer was able to
bind ssRNA (Fig. 16).

However, we cannot rule out that

during the refolding procedures VP4 formed its oligomer
structure.

Whether the oligomerization of VP4 ls required

for its RNA-binding is not clear.

The VP4 native structure

is required for the RNA binding, since SDS-denatured VP4
lost RNA-binding activity (Fig. 12).
In the study of the rev protein of human immunodeficiency virus type 1 (HIV-1), tetramerization is
required for RNA binding (Zapp et al., 1991), and both the
oligomerization and RNA-binding domains are located at the

arginine-rich reglons.
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Whether VP4 uses the same mechanism

for RNA binding and oligomerization ls unknown.
Presently, five BTV proteins have been shown to
possess ssRNA-binding activity.
and Roy,

These include VP1

1989), VP3 (Loudon and Roy, 1992), VP4

study), VP6 (Hayama and Li, 1994), and NS2

(Urakawa

(this

(Huismans et

al., 1987; Thomas et al., 1990; Zhao et al., 1994).
Interestingly, none of these BTV proteins bind ssRNA ln a
sequence-specific manner.

This contrasts with the

situation in rotavirus, in which some of the RNA-binding
proteins

(VP1, NSP1, and NSP3) possess specific affinity

for rotavirus mRNA, and others (VP2, NSP2, and NSP5) have
nonspecific binding activity (Patton, 1995).

How BTV

specifically encapsidates the 10 mRNAs through these
nonspecific RNA-binding proteins still needs to be
answered.
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FIG. 6.

Expression of VP4 in a baculovirus expresslon

system.

(A) Coomassie blue stained SDS-PAGE; Lane 1 and 2:

insect cells infected with recombinant baculovirus carrylng
BTV-13 M1 gene at an M.O.I. of 10 and 5, respectively; Lane
3: mock infected insect cells; Lane M: molecular weight
markers.

(B)

Immunodetection of the same sample as

described ln (A) with PAb against BTV-13 virion at 1:1,000
dilution.

(C) same as (B) except the antibody was pre-

immunized rabbit serum as a negative control .

.·
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FIG. 7. SDS-PAGE analyses of purified BTV-13 VP4 from the
baculovirus expression system.

VP4 purified by Sephadex G-

75 column was resolved by an SDS-PAGE and stained by (A)
Coomassie blue and (B) silver.
dilutions of VP4.

Lane 1 to 5 are two-fold
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p

FIG. 8.

76 77 78 80 81 82

Western blot immunodetection of VP4 by OAbs.

VP4

was tran sferre d to a nitrocellulose membrane after g el
el e ctrophoresi s through a 7.5 % SDS-polyacrylamide gel.

The

dilution s of OAb #76 and # 77 were 1:250 and 1:500; the
di lut ion s of OAbs are showed above the lanes ; pre-immuned
r abb it serum was used as a negative control

(labele d as P ).
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FIG. 9.
ln ELISA.

of

o·

1

antibodi es

Binding of anti-VP4 MAbs and OAbs to purified VP4
The degree of binding of these antibodies to VP4

was measured by the binding of alkaline phosphataseconjugated second antibodies and the optical density at 405
nm.

Pre-immuned rabbit serum and anti-VP6 MAb (Hayama and

Li, 1994) were used as negative controls.
each antibody were

The dilutions of

1:10, 1:100, 1:1,000, and 1:10,000.

Each point represents the average of three replicates.
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M 8

II

C ,_77?110 II

. VP4

~

8

A

FIG. 10.

C ,_ 77 l8 110 II

Competition binding of two anti-VP4 MAbs to VP4

by synthetic peptides.

MAb D3.6.24 and D3.10.1 were cross-

absorbed with VP4 sequence-specific peptides #76,

#77, #78,

#80, and #81 before they were used for immunodetection.
(A) MAb D3.6.24;

(B) MAb 03.10.1.

Lane M: pre-stained

molecular weight markers (Bio-Rad); Lane B: negative
control; Lane C: MAb without cross-absorption.

The band

across the blots above VP4 is due to the second antibody
cross-reaction.
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I

2 3 4

I

2 3 4

.

~Free

A

RNA

B

FIG. 11. EMSA of ssRNA-binding activity of VP4.

(A)

Various amount s of purified BTV-13 VP4 were used to react
with [ 32 P]-lab eled c apped RNA transcripts of BTV M1 gene.
Lane 1: labele d transc ript without VP4 as control; Lane 2:
20 ng of VP4; La e 3 : 40 ng of VP4; Lane 4: 80 ng of VP4.
(B) Competiti on betwe en capped and non-capped RNA for VP4
binding.

Var ious amo unts of unlab eled non-capped BTV-13 M1

transcripts were add ed to the reacti on mixture and the
experiment was per a r med a s in (A) .

Lane 1: no competitor

. RNA; Lane 2 : 1 0 0 ng ; Lane 3 : 2 0 0 ng; Lane 4 : 4 0 0 ng of
unlabeled non- e pped ssRNA.
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1 2 3 4 5 6
~

RNA- VP4 COJII)l.ex

FIG. 12 Compet ition between tRNA and BTV ssRNA for VP4
binding in EMSA.

Lane 1: Labe led

[ J ~ P]-RNA

with out VP4 as

control; Lane 2: 40 ng of VP4; Lane 3 : 80 ng of VP4; Lane
4: 500

~g

of yeast tRNA was includ ed in the reaction

mixture; Lane 5: same as lane 3 except 1 % SDS was adde d ln
the rea ction mixture; Lane 6: ssRNA was incubated with
RNase A.
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I
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1
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•
•

A

~4

~AU

B

FIG. 13. In vit ro t ranslation of BTV-13 VP4 and an internal
deletion mutan t

(/P4 ~LZ)

with wheat germ extract.

(A)

Translation of intac t VP4 from the capped RNA transcript of
the M1 gene

(L ane 1) and from non-capped M1 gene transcript

(Lane 2).

(B)

Transl ations of the intact M1 gene

transcript

(Lan e 1) and internal M1 deletion mutant which

lacks the leucin e - zi pper domain

(VP4~LZ)

(Lane 2).
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123456C

--

VP4

A

12 3 4 56 7C
--

VP4~LZ

B

FIG. 14.

Pr ofiles of VP4 and

poly(U)-seph arose column .

VP4~LZ

eluted from a

In vitro translated proteins

labeled with [ 35 S]-methionine were applied to a poly(U)sepharose column, eluted with 0.15 M NaCl, and collected.
The eluants were precipitated with TCA and resolved in SDSPAGE and autoradiographed.
numbers.

(A)

In tact VP4 ;

zipper regi on deleted

The numbers indicate fraction
(B) Truncated VP4 with leucine-

(VP4~LZ).
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2

3

4

5

6

1 2 3

4 5

_,_ ....... ....,

A

6

--·· ._. ~ Trx-VP4
.......C VP4

B

FIG. 15. Northwestern assay of VP4 expressed in insect
cells and E. coli.
heads.

VP4 and Trx-VP4 are indicated by arrow

(A) Expressed VP4 probed with [ 32 P] -ssRNA.

Immunodetection to the same membrane with OAb #82.

(B)
Lane 1-

3 were VP4 expressed in SF-9 cells with about 0.5, 1, and 2
pg of proteins,

respectively.

Lane 4-6 were Trx-VP4 fusion

proteins expressed in E. coli with about 0.5, 1, and 2 pg,
respectively.
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VP4 63X 654 624 6 81 618 6 58 667

VP4 63X 654 624 681 618 658 667

teo

OAb 181

OAb

667 658 618 68 1 624 654 63X VP4

667 658 618 681 624 654 63X VP4

OAb 182

OAb 178

FIG.

16.

proteins.

Immunodetection of Trx-VP4 and the truncated VP4
OAbs # 78,

80,

81, and 82 were used for th e

detection at a dilution of 1:1000.
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VP4

FIG . 17.

~3 X

~54

~24

~81

~lB

~58

~67

Hap ing the ssRNA-binding domains of VP4 with

No rth wes cr1

c-u . . l-4.~~.

i mmobilized

TP4 and

~,

nitrocellul o~

)

'

[ - p] -ssRNA was used to probe

he trunc ated VP4 proteins on a

membrane .
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ssRNA binding of oligopepti~es

10

5

2.5 1.25 0.62 0.31 0.15

ug

BSA

••

76
77

78
80

81

1 2 3 4 5 6 7

3

riG. 18 .
p pt:l es .

used
r.1emb

2p-SJ
transcript
(SOng)

+++++++

peptide (O.S ug)

-

76

77

78

80

81

82

s sRNA- binding activity of VP 4 se qu enc e -specific
(A) No rthwestern assay.

Bi o tinylated ssRNA was

o p robe the immobilized peptides on nitrocell ulos e
an .

(B ) EMSA.

132

0

1

2

4

.

584
487
389

292
194

97

FIG . 19.
VP4 .

Chemical cross-linking of

~n

Translated VP4 was incubated with

vitro t r a nsl a ted
0.01 ~

glu taraldehyde for 1, 2, and 4 min at r oom t emp e rature.
Cro s s -linked products were analyzed by

3 . 5~

SD S-PAGE .
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0

FIG. 20.

2.5

5

10
.......

Oligomer

.......

VP4~LZ

Monomer

Chemical cross-linking of VP4 with deleted

leucine-zipper motif

(VP4~LZ).

In vitro translated

truncated VP4 protein lacks the leucine-zipper motif
(VP4~LZ)

was incubated with 2.5, 5 , and 10 rnM of DMS at

room temperature for 25 min and analyzed on 7.5 % SDS-PAGE.
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CHAPTER IV
CONCLUSION AND DISCUSSION

Bluetongue Vlrus (BTV)

ls the agent that causes

bluetongue disease in ruminants.

The mechanism of BTV

replication is still largely unknown.

The transcription of

BTV ssRNA and the replication of BTV dsRNA were assumed to
be controlled by three lnner core proteins: VP1, VP4, and
VP6.

The functions of these inner core proteins are still

not clear.

VP1 is the potential RNA-dependent RNA

polymerase (Urakawa and Roy, 1989) .

VP6 is a DNA- and RNA-

binding protein (Hayama and Li, 1994).

VP4 is another

minor inner protein of BTV, and its function is unknown.
To understand the replication of BTV, the function of each
viral protein must be known.

In this study, the gene (M1)

coding for VP4 was cloned and sequenced.

VP4 was expressed

and purified in order to study its functions.
Phylogenetic study of BTV
using Ml genes

The length of five M1 genes determined in this study is
1981 nucleotides, 30 nucleotides shorter than that of the BTV
serotype-10 reported by Yu et al.

(1987).

The 5'- and 3'-

noncoding regions of all five M1 genes are identical among
all serotypes.

The M1 gene possesses a single, long ORF that
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encodes 644 amino acid residues.

A potential leucine-zipper

motif was identified near the carboxyl terminus of the
deduced VP4 amino acid sequence.

There is a high degree of

sequence conservation among the five US BTV VP4 proteins
with f e wer than 4% mismatches in their amino acid sequences
(Table 2).

The phylogenetic analysis using the sequences of

these five cognate M1 genes yielded results consistent with
our previous phylogenetic studies of cognate genome segments
1, 3, 5, 6, 8, 9, and 10.

Serotypes-10, -11, -13, and -17

are closely related, and serotype-2 is the most distantly
related among the five US BTVs (Fig. 4).
Characterization of VP4

Recombinant VP4 was expressed and found to be highly
insoluble in both eukaryotic (insect cells and yeast)
prokaryotic (GST-, Trx-, and 6xH-fusion proteins)

and

systems.

When detergents and reducing agents were combined, the
heterologously expressed VP4 was able to be solubilized and
purified to near homogeneity (Fig. 7).

The recombinant VP4

possessed a ssRNA-binding activity in both the EMSA (Fig.
11) and the Northwestern assay (Fig. 15).

VP4 protein has

binding activity to both capped and non-capped ssRNAs.

Its

RNA-binding activity was not specific to BTV ssRNA as it
was demonstrated that in vitro translated VP4 could bind to
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poly(U)-sepharose (Fig. 14), and its BTV ssRNA-binding
activity could be competed out by yeast tRNA (Fig. 12).
Although a leucine-zipper motif is found in many proteins
(summarized in Table 5) including nucleic acid binding
proteins, the leucine-zipper of VP4 is not required for the
RNA binding (Fig. 14 and 17).

An RNA-binding domain was mapped between amlno acid
residues #112-158.

AnN-terminal truncated VP4 was

constructed (mutant

~67)

to

invest~gate

whether residues

#112-158 are the only ssRNA-binding domain.
~67,

The mutant

which lacks amlno acid residues #112 to 158, retained

ssRNA-binding activity (Fig. 17).

This suggests that more

than one ssRNA-binding domain exists in VP4.
To identity other potential ssRNA-binding domains of
VP4, sequence-specific synthetic peptides corresponding to
VP4 in the arginine- and lysine-rich regions were used ln
EMSA and Northwestern assays (Fig. 18).

These regions are

located at amino acid residues #103-115 (ENEIGRRRIRMRK),
#376-385 (RDRGTFLKKR), #583-592
(RALREYKRK) .
residues

(KEQKLRDLKR), and #617-626

These sequences are rich in basic amino acid

(Rand K), which are found in many of the RNA-

binding proteins (Merrill et al., 1988; Lazinski et al.,
1989; Nagai et al., 1990).
accessible on VP4

These regions are also surface

(Fig. 9 and 21) and thus are more
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available for binding to RNA.

The RNA-binding domains are

summarized in Fig. 23.
VP4 was suggested as an oligomer based on chemical
cross-linking experiments (Fig. 19), but additional data
have to be collected to confirm this conclusion.
leucine-zipper motif

lS

The

not required for the

oligomerization (Fig. 20), although it is responsible for
oligomerization in some other proteins (Landschulz et al.,
1988; Sorger and Nelson, 1989).

Whether the

oligomerization of VP4 is required for its RNA-binding
activity is not clear.

The nondenatured form of VP4 is

required for the RNA-binding; in the presence of SDS, VP4
was not able to bind ssRNA in EMSA (Fig. 12).
Mapping the antigenic
epitopes of VP4

Six antigenic epitopes were mapped at am1no acid
residues #617-626 (RALREYKRKM), #583-592
#167-178

(GARFDDEPTDEK), #376-385 (RDRGTFLKKR), #103-115

(ENEIGRRRIRMRK), and #523-551
RMGLDL)

(KEQKLRDLKR),

(Fig. 8).

(RVESSVLRVRNPTLHETADELK

These regions are also surface

accessible as shown in ELISA (Fig. 9).

Peptide competition

assays for blocking two monoclonal antibodies

(D3.6.24 and

D3.10.1) also confirmed that #617-626, #376-385, and #103-
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115 are surface accessible (F i g. 9) and that the two
antigenic determents are conformational.
Potential function of VP4

Although VP4 is the candidate for being the BTV
guanylyltransferase, its sequence is not similar to any of
the known guanylyltransferases and capplng enzymes.

Using

the FASTA program of GCG to search for homology between VP4
and other known proteins, I found that amino acid residues
between #7 and #41 have 47.6% identity in a 21-amino acid
overlap to the RNA-directed RNA polymerase of human
respiratory syncytial virus, which is a ssRNA Vlrus.

This

region also has 33.3% identity in a 21-amino acid overlap to
the RNA-directed RNA polymerase of kunjin virus, which ls
also a ssRNA virus (Fig. 22A).

Another region between amlno

acid residues #533-587 was also found to have 27% identity ln
a 37-amino acid overlap to the B-subunit of the RNA
polymerase of vesicular stomatitis virus, which ls a ssRNA
Vlrus.

The same region also has 37.5% of identity ln a 16-

amino acid overlap to the RNA-directed RNA polymerase (ORF1A)
of coronavirus (Fig. 22B).

One of the common characteristics

of these RNA polymerases is that they are multifunctional
proteins.

They may be involved in RNA synthesis, capplng,

and methylation.

Perhaps VP4 interacts with VP1, the BTV RNA
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p olymer as e, to form the transcription and replication complex
through leucine-zipper motifs predicted from both proteins.
Future research of VP4

This is the first report in which the BTV VP4 protein
has been purified to near homogenity and identified as a
ssRNA-binding protein, although the structure and
functional domains were mapped using recombinant VP4
proteins and sequence-specific peptides.

To confirm the

RNA-binding domains of VP4, crystallization is required.
The technique developed for purifying VP4 can be used to
prepare large amounts of VP4 for crystallization.

The same

technique may also be applied to purify other BTV proteins
that are expressed as insoluble forms.
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TABLE 5

Summary of the Functions of Leucine-Zipper
Motif in Some of the Known Proteins
Protein

Function

Reference

Yeast, heat shock
transcription factor

Trimerization

Sorger and Nelson,
1989

Yeast, GCN4

Dimerization
DNA binding

Pu and Struhl, 1991

Reovirus, slgma 1
protein

Trimerization

Leone et al., 1991

Hepatitis delta
antigen

Dimerization
RNA replication

Xia and Lai, 1992

Measles Vlrus, fusion
protein

Fusion

Buckland et al. ,
1992

Newcastle disease
virus, fusion protein

Fusion

Reitter et al.,
1995

Fujinami sarcoma
virus, p130-gag-fps

Trans-activation of
tyrosine kinase

Park and Seo, 1995

Marek's disease
virus, Meq protein

Dimerization

Qian et al., 1995

Human T-cell leukemia
Vlrus type-1, CREB1

Protein-Protein
interaction

Yin et al., 1995
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FIG. 21. Protein structure prediction and epitope
location s of VP4.

The secondary structure of VP4 was

predicted using the PlotStructure program of GCG software.
The locations of six epitopes were marked as black blocks.
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BTV-13 VP4

7-VLYVTNELSH.IVKNG.FLPIWKLTGDESLNDLWLEN

Rrpl_Hrsva

389-SDNIINGR . . WIILLSKFLKLIKLAGDNNLNNLS.EL

Polg_Kunjm

970-NLAIHSDLSYWIESR .. FNDTWKLERAVLGEVKSCTW

--

-

-

A

BTV13 VP4
Rrpl_Vsvsj

-

874-KYAMLYLDPS.IGGVSGMSLSRFLIRAFPDPVTESLS.FWRF.IHVHAR.SEHLKEMSA

-

----

---

-

B

FIG. 22.

Sequence alignment of VP4 to other proteins using

FASTA program of GCG software.
between #7 to 41.

(A) The amlno acid residues

Rrpl_Hrsva: RNA polymerase of human

respiratory syncytial virus; Polg_Kunjm: RNA polymerase of
kunjin virus.
587.

(B) The amino acid sequence between #533 to

Rrpl_Vsvsj: RNA polymerase of vesicular stomatitis

virus; Rrpa_Cmvjh: RNA polymerase of coronavlrus.

The

identical amlno acids are balded and underlined, and
numbers at left show residue numbers.
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81 78

80

82 77 76

RNA-binding
VP4

87 kDa

~3X

75

~54

41

yes

~24

40

yes

~81

32

-168

~18

24

--111

no

~58

20

--76

no

~67

32

yes

468

Synthetic peptides

#76
#77
#78
#80
#81

RALREYKRKM
KEQKLRDLKR
GARFDDEPTDEK
RDRGTFLKKR
ENEIGRRRIRMRK

yes

yes

yes

Locations

#617-626
#583-592
#167-178
#376-385
#103-115

RNA-binding

yes
yes
no
yes
yes

FIG. 23. Summary of the truncated VP4 proteins and the VP4
RNA-binding domains.

The locations of the peptides are

· indicated as arrow heads and are also summarized at the
bottom of the figure.
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APPENDIX A.1
SEQUENCE ANALYSES AND ANTIGENIC EPITOPE MAPPING OF
THE PUTATIVE RNA-DIRECTED RNA POLYMERASE OF
FIVE U.S. BLUETONGUE VIRUSES 1
I-Jen Huang, 2 Guang-Yuh Hwang,

Emiko Hayama,
1

2

3

Yi-Yuan Yang,

and Joseph K.-K. Li 2
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Department of Biology, Tunghai University, Taichung,
Taiwan, Republic of China; and

4

Department

of Medical Technology, Taipei Medical
College, Taipei, Republic of China
(Published ln 1995: Virology 214, 280-288)
ABSTRACT
We determined the complete nucleotide sequences of the
cognate Ll double-stranded RNA segment of bluetongue virus
(BTV) serotypes 2, 11, 13, and 17, which encode the
putative RNA-directed RNA polymerase VP1.

Each Ll gene

contained 3944 nucleotides and was 10 bases shorter than
the previously reported L1 gene of BTV 10.

A single open

frame which could encode the reported VP1 protein, 1302
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amlno acids ln slze, began with an initiation codon at
nucleotides 12-14 and a termination codon at nucleotides
3918-3920.

Analyses of the nucleotides of L1 gene and the

deduced amino acid sequences of VP1 proteins of the five
U.S. BTV serotypes indicated that the most recently
isolated BTV-2 serotype from Florida was more distantly
related than BTV-10, -11, -13, and -17, which were isolated
prlmary in the western U.S.A.

The results are consistent

with our hypothesis that BTVs-10, -11, -13, and -17 are
derived form a single and common gene pool, and that BTV-2
belongs to a second, distinct gene pool.

These genetic

distinctions also reflected well with the known geographic
distribution of the five U.S. BTV serotypes in North
America.

This putative RNA-directed RNA polymerase (149

kDa) was a basic protein, and the deduced amino acid
sequences of the VP1 proteins contained seven highly
conserved hydrophobic domains and many other sequence
motifs which were also found in other known RNA
polymerases.

Four immunodominant but linear antigenic

epitopes conserved among the VP1 of five U.S. BTVs were
also been identified and mapped using monospecific
oligoclonal antibodies.
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APPENDIX A.2
CONSERVATION OF THE SEGMENT 4 GENE SEQUENCE AND OF
A LEUCINE ZIPPER MOTIF IN VP4 AMONG
FIVE US BLUETONGUE VIRUSES 1
I-Jen Huang, Emiko Hayama, Yoo-Jin Jeong,

and Joseph K.-K. Li
1

Permission to reprint lS granted by Academic Press,

Inc.

Program in Molecular Biology and Department of Biology,
Utah State University, Logan, Utah 84322-5500, USA
(Published ln 1993: Virology 195, 772-779)
P.S. The results of this paper represent part of this
dissertation.
ABSTRACT
Full-length eDNA coples of the segment 4 (Ml) genes of
US Bluetongue viruses serotype-2, -10, -11, -13, and -17 were
selectively amplified using genomic double-stranded RNA
segments from purified BTV virions as templates and a
modified polymerase chain reaction (Clamp-R) .

They were then

cloned into pUC19 plasmids and both strands of several clones
were sequenced.

The length of all five segment 4 genes lS

1981 nucleotides, which is 30 nucleotides shorter than that
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of the BTV serotype-10 reported by Yu et al.

The 5'- and 3'-

noncoding regions of all five segment 4 genes are identical
among all serotypes.

The plus sense strand of the BTV

segment 4 gene, which encodes the VP4 protein, possesses a
single long open reading frame with an

init~ation

codon (ATG)

at nucleotides #9-11 and a stop codon (TAA) at nucleotides
#1941-1943.

This open reading frame encodes for a protein of

644 amino acid residues with a predicted molecular weight of
about 75 kDa and a pi of +7 to +7.9. A potential leucine
zipper motif was detected near the carboxyl terminus of the
deduced VP4 amino acid sequence.

The phylogenetic analysis

using the sequences of these five cognate segment 4 genes lS
consistent with the results of our prevlous phylogenetic
studies of cognate genome segments 5, 6, 8, 9, and 10.
Serotype-10, -11, -13, and -17 are closely related and
serotype-2 is the most distantly related among the five US
BTV serotypes.
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EVOLUTIONARY ANALYSES OF FIVE US BLUETONGUE VIRUSES
USING THE COGNATE S2 GENES 1
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ABSTRACT
Full-length eDNA coples of S2 genes

(segment 8),

coding for nonstructural protein 2 (NS2) of bluetongue
virus serotypes 2, 11, 13, and 17 were selectively
synthesized by a modified polymerase chain reaction (ClampR)

and cloned into the Pst I site of the pUC19 plasmid.

Each of these S2 cognate genes was 1125 nucleotides in
length with an initiation and a termination codon at
nucleotides #20-22 and #1082-1084, respectively, resulting
in a long open reading frame capable of coding a protein of
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354 amino acids.

The deduced amlno acid sequence of NS2

protein had a high concentration of lysine and contained a
relatively low number of tryptophan and histidine residues.
There was a highly conserved hydrophilic region at the
carboxyl termini of predicted NS2 proteins in all five BTV
serotypes, even though the amino acid sequence in this
region in BTV-2 was more variable than in the other four
serotypes.

There was significant sequence homology of the

cognate S2 genes at both the nucleotide and the amino acid
levels.

Phylogenetic analyses using the S2 gene sequences

indicated that BTV-10, -11, -13, and -17 were more closely
related and BTV-2 was the most distantly related serotype
among the five US bluetongue viruses.
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EXPRESSION AND PURIFICATION OF BTV-13

VP4 IN E.COLI

MATERIALS, METHODS, AND RESULTS

Expression of VP4 as GST
fusion protein

Full-length eDNA of the BTV-13 M1 gene was amplified
as described in CHAPTER II with a pair of primers anchored
with a Sma I site (5'-GACGTCGACCCGGGGATGCCTGAGCCA-3' and
5'-GACGTCGACCCGGGTAAGTTGTACAT-3').

The amplified eDNA was

cloned into the pGEX2T expression vector (Pharmacia) at the
Sma I site using the procedures described ln CHAPTER II.
The orientation of the insert was checked by BamH I enzyme
digestion.

The plasmid containing BTV-13 Ml eDNA

(pGEX2TBTV13Ml) was then transformed into E. coli TOPP2
strain (Stratagene) as described in CHAPTER II for
expresslon.

The expressed VP4 was a GST-VP4 fusion

protein.
One ml of overnight culture grown in LB containing 50
pg/ml of ampicillin at 34 ° C was diluted 8-fold with LB and
· allowed to grow for 1.5 hr.

Isopropyl-B-D-thiogalacto-

pyranoside (IPTG) was added to the culture at a final
concentration of 0.05 mM as an inducer to initiate the
protein expression.

After 2.5 hr of induction at 34 ° C,

155
the cells were harvested by centrifugation at 4,000 rpm for
10 min and resuspended in 1 ml of ice-cold MTPBS

(150 mM

16 mM Na 2P04, 4 mM NaH2P04, pH 7.3) plus 50 mM EDTA, 1

NaCl,

mM phenylmethylsulfonylfluoride (PMSF), and 1 % TX-100.
cells were then lysed by sonication (VirSonic,
output)

The

80% power

three times (30 sec each) at 4° C and centrifuged

at 4,000 rpm for 15 mln to separate the soluble and
insoluble fractions.

The expressed GST-VP4 was found

mainly in the insoluble fraction (data not shown) .

By

lowering the temperature to 15° C for growlng and
expresslon, the production of soluble GST-VP4 protein
increased.

.

However, the overall amount of protein

production was reduced tremendously (data not shown)
The insoluble pellets were resuspended in 1 ml of 25
mM triethanolamine, pH 8, 1mM EDTA, and 1.5 % N-lauroyl
sarcosine and incubated at 4° C for 25 min.

TX-100 was

then added to the protein solution to a final concentration
of 1 %.

The solution containing GST-VP4 was then incubated

with 20 pl of glutathione-conjugated agarose beads

(G-

beads, Sigma), pre-equilibrated with the same buffer at
4° C,

for 1 hr to extract the GST-VP4 fusion protein.

GST-VP4 bound to the G-beads through the GST moiety.

The
The

G-beads were then washed 3 times with 1 ml of 100 mM TrisHCl, pH 7.5 and 150 mM NaCl, and another 3 times with the
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cleavage buffer (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, and
2.5 mM CaCl 2).

As shown in Fig. 23A, the G-beads were able

to extract GST-VP4 from the protein solution with minor
contamination.

The intact VP4 was released from the G-

beads by protease digestion at room temperature with human
thrombin (0.5 u/ml), which cleaved the junction sequence
(LVRRGS) between GST and VP4.

As shown in Fig. 23B, after

thrombin digestion, the amount of GST-VP4 fusion protein
(102 kDa) decreased and the amounts of VP4
(27 kDa)

(75 kDa)

and GST

increased.

Expression of VP4 as 6xH-VP4
fusion protein

BTV-13 M1 eDNA was also cloned into the pQE30

(Qiagen)

expression vector at the Sma I site using the procedures
described previously.

The plasmid carrying the correct

orientation of BTV-13 M1 eDNA (pQE30BTV13M1) was
transformed into to E. coli strain M15 (pREP4)
expresslon.

(Qiagen)

for

VP4 would be expressed as a fusion protein

tagged with 6-histidines (6xH-VP4)

in this system.

Ten ml

of the overnight culture grown at 37 ° C was diluted with
growth media at a 1:20 dilution and allowed to grow for 3
hr.

IPTG was then added to the culture at a final

concentration of 2 mM to initiate the protein expression.
As shown in Fig. 24, E. coli grown in different media had

different efficiencies of 6xH-VP4 protein expression.
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In

the comparison of 2xYT (16 g ·bacto-tryptone, 10 g bactoyeast extract, and 5 g NaCl per liter), Super Broth (25 g
bacto-tryptone, 15 g bacto yeast extract, and 5 g NaCl per
liter), and LB (10 g bacto-tryptone, 5 g bacto-yeast
extract, and 10 g NaCl per liter), 2xYT gave the best yield
in the expression of 6xH-VP4, and LB gave the lowest
efficiency of expression.

The 6xH-VP4 was also expressed

as insoluble inclusion bodies.

Lowering the growth and

induction temperatures, and using different dilutions of E.
coli culture and induction times did not change the

formation of inclusion bodies.

The expressed 6xH-VP4 was

then purified in the denatured form using Talon™ resin
(Clontech), which is a non-nickel immobilized metal
affinity resin, to purify recombinant 6xH proteins.

The

induced E. coli culture was harvested by centrifugation at
4,000 rpm for 10 min, and the pelleted cells were
resuspended in 10 ml of STE (10 mM Tris-HCl, pH 8, 150 mM
NaCl, 1 mM EDTA) buffer.
sonication 5 times

The cells were lysed by

(30 sec each), and the lysed cells were

then centrifuged at 4,000 rpm for 15 min to separate the
soluble and insoluble fractions.

The insoluble fraction

containing 6xH-VP4 was dissolved in 10 ml of

buffer

containing 20 mM Tris-HCl, pH 8, 100 mM NaCl, and 6 M
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guanidine-HCl for 10 mln at room temperature.

The protein

solution was then centrifuged at 10,000x g for 10 min to
remove any insoluble materials.

The majority of 6xH-VP4

was found in the supernatant (data not shown) .

The

supernatant containing the 6xH-VP4 was then mixed with 1 ml
of Talon™ resin pre-equilibrated with the same buffer at
room temperature for 20 min to extract the 6xH-VP4 protein.
The resin was then washed with the same buffer for 10 min
to remove unbound proteins.

The washed resin was then

packed into a 10-ml column.

Elution buffer (20 mM Tris-

HCl, pH 8, 100 mM NaCl, 8 M urea) containing different
concentration of imidazole (5 ml of each concentration) was
used to elute the 6xH-VP4, and 1-ml fractions were
collected.

As shown in Fig. 25, the 6xH-VP4 eluted at 40

mM imidazole.
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FIG. 24. SDS-PAGE analyses of purified GST-VP4 fusion
proteins.

(A) GST-VP4 fusion protein purified with

glutathione- conj ug ated aga ro se beads in two preparations.
Lane M: Molecular weight markers shown as kDa.

(B)

Thrombin cleavage of the purified GST -VP4 fusion protein.
Lane 1: GST-VP4 fusion protein without thrombin; Lane 2: 10
mln; Lane 3 : 30 min ; Lane 4:

60 min; Lan e 5: 90 min

incubation with thr ombin at room temper ature.
were stained with Coomassie blue .
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FIG. 25. SDS-PAGE analyses of the 6xH-VP4 fusion proteins
expressed in different growth media.

E.

coli carrying

pQE30BTV13Ml plasmid was grown in Super Broth, LB, and 2xYT
media, respectively and induced with 2 mM IPTG for protein
expresslon.

The samples were analyzed on a 7.5 % SDS-PAGE

and stained with Coomassie blue.

Numbers on top of the gel

represent the hours post induction (hr/pi).

Molecular

weights were indica ed on the right side of the figure
( kDa) .
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FIG. 26. Purif ica tion of 6xH - VP4 under denat uring
condition s .

Expre ssed 6xH-VP4 was extracte d by Talon™

resin and elut ed wi th 5 ml of 10 mM (Lanes 1 to 5), 20 mM
(Lanes 6- 10) , 4 0 mM (Lanes 11 to 15) , 80 mM (Lanes 16 to
20),

100 mM (Lanes 21-25) , and 200 mM (Lane s 26 to 33)

imidazole in t he e lution buff er .

One-ml fr actions were

collected and 1 0 p l of each frac lon were an alyzed on 7.5 %
SDS-PAGE an

st ain ed with Coomassie blue .

Molecular weigh t ma rkers

Lane M:

(200 , 11 , 97 , 66 , and 55 kDa).

Lane R: Talonr 1 re sin with bound

xH-VP4 .
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COEXPRESSION OF VP4 AND VP6 IN INSECT CELLS
MATERIALS, METHODS, AND RESULTS

Because VP4 that was expressed in both eukaryotic and
proka r yotic cells was ln the insoluble form,

I investigated

whether co-expressing it with another inner core protein
would increase its solubility in insect cells.
and S3

BTV-13 Ml

(codes for VP6) cDNAs were cloned into the pAcUW51

(Invitrogen) baculovirus expression vector.

The vector has

two promoters (p10 and polyhedrin) to express two genes ln
the same insect cell.

Full-length BTV-13 S3 eDNA was

amplified as described in CHAPTER II using a pair of prlmer
anchored with an EcoR I site (5'-GGATCCGAATTCGTTAAAA
AATCGCATAT-3' and 5'-GGATCCGAATTCGTAAGTGTGAAATCGCC-3') and
cloned into the vector pAcUW51 at the EcoR I site
(pAcUW51BTV13S3).

Two pg of the pAcUW51BTV13S3 plasmids

were then digested with the BamH I restriction enzyme ln 20
pl of reaction mixture.

To fill ln the BamH I digested

sticky ends to generate blunt ends, 1 pl of each 0.5 mM
dNTP and 5 units of Klenow were added to the mixture and
incubated 15 min at 30° C.

The blunt-ended plasmids were

then purified by phenol/chloroform and ethanol precipitated
as described in CHAPTER II.
with Sma I

The BTV-13 M1 eDNA digested

(also blunt ended) was ligated to the blunt-
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ended linear pAcuW51BTV13S3 plasmid to construct the
pAcuW51BTV13S3-M1 plasmid.
summarized in Fig. 26.

The plasmid construction was

The plasmid purification and co-

transfection with linear viral DNA were according to the
procedures described in CHAPTER III.

As shown in lane T of

Fig. 27, the recombinant baculovirus infected insect cells
expressed both VP4 and VP6.

However, the expressed VP4 was

mainly in the insoluble portion (Lane P, Fig. 27), whereas
VP6 was soluble (LaneS, Fig. 27) . · To investigate whether
VP4 and VP6 formed a complex in vivo, co-immunoprecipitation was carried out with anti-VP6 MAbs (D34.5.7, D12.4.20,
and H13.1).

Insect cells infected with recombinant

baculovirus were harvested after 72 hr post infection and
lysed in lysis buffer (50 roM Tris-HCl, pH 7.5, 150 mM NaCl,
1 mM EDTA, 0.1% NP-40).

The lysed cells were centrifuged

to separate the soluble and insoluble fractions.

Fifty pl

of each MAb were mixed with 250 pl of the supernatant, and
incubated at 4° C for 1 hr.

At the end of incubation, 50

pl of protein A-sepharose (50% v/v in PBS) were added to
the solution and incubated at 4° C for 1 hr.

The sepharose

was then washed with the same buffer 3 times to remove the
unbound antibodies and proteins.

The protein-antibody

complexes bound to the protein A-sepharose were solubilized
by the SDS-PAGE sample buffer and analyzed by western blot
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immunodetection using anti-VP4 or VP6 OAbs.

As shown in

Fig. 28, the VP6 protein was immunoprecipitated by anti-VP6
MAbs.

However, VP4 did not co-precipitate with VP6.

The

result indicated that VP4 and VP6 did not form a complex
v~vo.

Similar results were obtained when the yeast two-

hybrid system (Clontech) was used to investigate the
interaction between VP4 and VP6 (data not shown) .
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FIG. 27. Summary of the construction of pAcUW51BTV13S3-M1.
BTV-13 S3 cDNA·was cloned into the EcoR I site, and the
expresslon of VP6 was controlled · by the p10 promoter.

BTV-

13 M1 eDNA was cloned into the BarnH I site, and the
expresslon of VP4 was controlled by the polyhedrin
promoter.

#: the site of BarnH I was destroyed by filling

in the sticky ends to generate blunt ends.
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Analysis of the coexpresslon of VP4 and VP6 ln

insect cells by western blot immunodetection.

Insect cells

infected with recombinant baculovirus carrylng BTV-13 S3
and M1 eDNA were harvested, separated on SDS-PAGE, and
transferred to nitrocellulose membranes as described ln
CHAPTER III.

(A)

(1:1000 dilution).
(D34.5.7).

Immunodetection with anti-VP4 OAb
(B)

#82

Immunodetection with anti-VP6 MAb

Lane T: total cell lysate; LaneS: supernatant

(soluble portion); Lane P: pellet (insoluble fraction).
Duplicated samples were used for analysis.
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FIG. 29. Irnrnunopre cipitati on of insect cells coexpress1ng
VP4 and VP6 proteins.

The soluble fraction of the insect

cell lysate (as described in Fig. 27) was
immunoprecipitated with anti-VP6 MAbs
and H13.1).

(D34.5.7, D12.4.20,

The immunoprecipitated complexes were

separated on SDS-PAGE and transferred to nitrocellulose
membranes.
OAb #82

The membranes were immunodetected with anti-VP4

(1:1000 dilution) or anti-BTV virion PAb #79

(1:1000 dilution).

The results indicated that VP4 and VP6

proteins were not co-precipitated with anti-VP6 MAbs.
C: mock-infected cell lysate.

Lane
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TABLE 6

Results Obtained Using Different Reagents for
Purifying VP4 from Insect (SF-9) Cells

Lysis buffers (sonication)
1% NP40, 150 mM MgCh,

Solubilization buffers

Solubility*
(1-5 scale)

Buffer for
dialysis

GTPbinding
activity

200 mM MgCh, 10 mM OTT,
50 mM Tris, pH 8

1

1.5% N-Lauroyl Sarcosine,
50 mM Tris, pH 8

5

PBS-ppt;
50mMTris
pH 8.8- ppt

No
(No RNA
binding,
either).

Same as above

100 to 500 mM EDT A.
50mM Tris, pH 8

2

10 mM Tris,
pH 8- ppt

Yes (dot blot)

Same as above

8 M urea (room temperature)

2.5

10 mM Tris,
pH 7.5-ppt

No

Same as above

8 M urea, 10 or 50 mM DTT (at room
temperature)

2.5

Same as above

6 M Guanidine-HCI

10 mM Tris,
pH 7.5-ppt

No

1% NP40, 10 mM EDT A.

100 mM EDTA

u

Same as above

1% Tw-20 in lysis buffer

0

Same as above

1% Chaps in lysis buffer

0

1% NP40, 1OmM EDT A.

100 and 500 mM EDT A. pH 9

u

Same as above

1% Tw-20 in PBS

0

Same as above

1%DOC in PBS

1

50 mM Tris, pH 8.

1% NP40, 1mM EDT A.
50mM Tris, pH 7.5

.

3.5

50 mM HEPES, pH 7.3

50 mM Tris, pH 8.8

1% NP40, 0.2 M NaCI,

No

0

10mM EDT A, 50mM Tris, pH 8
0.01% NP40, 150 to 500 mM
NaCI, or 150 mM MgCh

0.001 to 0.1% NP40

0.2 M NaC~ 10mM EDT A.
50mM Tris, pH 8

ppt: The protein

0

VP4was
detected in
supernatant
byOAb

precipitat~d

during the dialysis.

* Scale 5= soluble and scale 0= insoluble.

Yes
(supernatant
of lysis
buffer)
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